<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2020.563320</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Priming Astrocytes With HIV-Induced Reactive Oxygen Species Enhances Their <italic>Trypanosoma cruzi</italic> Infection</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Urquiza</surname>
<given-names>Javier</given-names>
</name>
<xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref>
<xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/982133/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cevallos</surname>
<given-names>Cintia</given-names>
</name>
<xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref>
<xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/897568/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Elizalde</surname>
<given-names>Mar&#x00ED;a Mercedes</given-names>
</name>
<xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref>
<xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Delpino</surname>
<given-names>M. Victoria</given-names>
</name>
<xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref>
<xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref>
<xref rid="c001" ref-type="corresp"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/263437/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Quarleri</surname>
<given-names>Jorge</given-names>
</name>
<xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref>
<xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref>
<xref rid="c002" ref-type="corresp"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/383280/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Instituto de Investigaciones Biom&#x00E9;dicas en Retrovirus y Sida (INBIRS), Facultad de Medicina, Universidad de Buenos Aires (UBA)</institution>, <addr-line>Buenos Aires</addr-line>, <country>Argentina</country></aff>
<aff id="aff2"><sup>2</sup><institution>Consejo Nacional de Investigaciones Cient&#x00ED;ficas y T&#x00E9;cnicas (CONICET)</institution>, <addr-line>Buenos Aires</addr-line>, <country>Argentina</country></aff>
<aff id="aff3"><sup>3</sup><institution>Instituto de Inmunolog&#x00ED;a, Gen&#x00E9;tica y Metabolismo (INIGEM), Facultad de Farmacia y Bioqu&#x00ED;mica, Universidad de Buenos Aires</institution>, <addr-line>Buenos Aires</addr-line>, <country>Argentina</country></aff>
<author-notes>
<fn id="fn1" fn-type="edited-by">
<p>Edited by: Rachel Daniels, Harvard University, United States</p>
</fn>
<fn id="fn2" fn-type="edited-by">
<p>Reviewed by: Matthew H. Collins, Emory University, United States; Dolores Correa, National Institute of Pediatrics, Mexico; Phileno Pinge-Filho, State University of Londrina, Brazil</p>
</fn>
<corresp id="c001">&#x002A;Correspondence: M. Victoria Delpino, <email>mdelpino@ffyb.uba.ar</email>, <ext-link ext-link-type="uri" xlink:href="http://orcid.org/0000-0003-2077-8509">orcid.org/0000-0003-2077-8509</ext-link></corresp>
<corresp id="c002">Jorge Quarleri, <email>quarleri@fmed.uba.ar</email>, <ext-link ext-link-type="uri" xlink:href="http://orcid.org/0000-0001-5110-8773">orcid.org/0000-0001-5110-8773</ext-link>
</corresp>
<fn id="fn3" fn-type="other">
<p>This article was submitted to Microbial Immunology, a section of the journal Frontiers in Microbiology</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>19</day>
<month>10</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>11</volume>
<elocation-id>563320</elocation-id>
<history>
<date date-type="received">
<day>18</day>
<month>05</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>09</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2020 Urquiza, Cevallos, Elizalde, Delpino and Quarleri.</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>Urquiza, Cevallos, Elizalde, Delpino and Quarleri</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p><bold>Introduction</bold>: <italic>Trypanosoma cruzi</italic> is an intracellular protozoa and etiological agent that causes Chagas disease. Its presence among the immunocompromised HIV-infected individuals is relevant worldwide because of its impact on the central nervous system (CNS) causing severe meningoencephalitis. The HIV infection of astrocytes &#x2013; the most abundant cells in the brain, where the parasite can also be hosted &#x2013; being able to modify reactive oxygen species (ROS) could influence the parasite growth. In such interaction, extracellular vesicles (EVs) shed from trypomastigotes may alter the surrounding environment including its pro-oxidant status.</p>
<p><bold>Methods</bold>: We evaluated the interplay between both pathogens in human astrocytes and its consequences on the host cell pro-oxidant condition self-propitiated by the parasite &#x2013; using its EVs &#x2013; or by HIV infection. For this goal, we challenged cultured human primary astrocytes with both pathogens and the efficiency of infection and multiplication were measured by microscopy and flow cytometry and parasite DNA quantification. Mitochondrial and cellular ROS levels were measured by flow cytometry in the presence or not of scavengers with a concomitant evaluation of the cellular apoptosis level.</p>
<p><bold>Results</bold>: We observed that increased mitochondrial and cellular ROS production boosted significantly <italic>T. cruzi</italic> infection and multiplication in astrocytes. Such oxidative condition was promoted by free trypomastigotes-derived EVs as well as by HIV infection.</p>
<p><bold>Conclusions</bold>: The pathogenesis of the HIV-<italic>T. cruzi</italic> coinfection in astrocytes leads to an oxidative misbalance as a key mechanism, which exacerbates ROS generation and promotes positive feedback to parasite growth in the CNS.</p>
</abstract>
<kwd-group>
<kwd>astrocytes</kwd>
<kwd><italic>Trypanosoma cruzi</italic></kwd>
<kwd>human immunodeficiency virus</kwd>
<kwd>reactive oxygen species</kwd>
<kwd>extracellular vesicles</kwd>
</kwd-group>
<contract-num rid="cn1">PICT-2015-1921</contract-num>
<contract-num rid="cn1">PICT-2015-0316</contract-num>
<contract-sponsor id="cn1">Agencia Nacional de Promoci&#x00F3;n Cient&#x00ED;fica y Tecnol&#x00F3;gica of Argentina</contract-sponsor>
<counts>
<fig-count count="5"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="70"/>
<page-count count="13"/>
<word-count count="10058"/>
</counts>
</article-meta>
</front>
<body>
<sec id="sec1" sec-type="intro">
<title>Introduction</title>
<p>The intracellular protozoan <italic>Trypanosoma cruzi</italic> (<italic>T. cruzi</italic>) causes Chagas disease, which is one of the most important current neglected diseases in the Americas and increasingly widespread worldwide. It is transmitted to humans by <italic>Triatoma infestans</italic> as vector. Current estimations from the World Health Organization (WHO) denote that 8 million people are infected and other 25 million people are vulnerable of acquiring <italic>T. cruzi</italic> infection worldwide (<xref ref-type="bibr" rid="ref49">Perez-Molina and Molina, 2018</xref>). Over the last decades of the twentieth century, chronically infected individuals with severe immunosuppression, such as transplant recipients and people living with HIV/AIDS (PLWHA), were at risk of severe forms of reactivation, such as Chagasic meningoencephalitis (<xref ref-type="bibr" rid="ref38">Lattes and Lasala, 2014</xref>). This condition can arise at chronic stage of infection in immunocompromised hosts including PLWHA (<xref ref-type="bibr" rid="ref8">Bern et al., 2011</xref>), and it is characterized by brain nodular lesions usually called chagomas involving macrophages, neutrophils, microglia, astrocytes, and perivascular lymphocytic infiltrate in various foci along the central nervous system (CNS; <xref ref-type="bibr" rid="ref27">Gomez and Banaei, 2018</xref>). Astrocytes are the most abundant brain cells and have multiple functions including maintenance of an adequate environment for neurons by providing metabolic support and modulating synaptic transmission. Moreover, they promote myelination activity of oligodendrocytes and nervous systems repair (<xref ref-type="bibr" rid="ref59">Sofroniew and Vinters, 2010</xref>; <xref ref-type="bibr" rid="ref36">Kiray et al., 2016</xref>).</p>
<p><italic>T. cruzi</italic> life cycle comprises the trypomastigote as infective bloodstream-form able to infect different nucleated cells. Cell infection is a complex process and includes the parasite-cell uptake, an endocytic process with modification of cellular cytoskeleton, and the growth of a parasitophorous vacuole that encloses trypomastigotes. These trypomastigotes escape into the cytoplasm to be transformed in the amastigote form, able to multiply intracellularly by binary division. Intracellular amastigotes sustain metabolic dependence on cellular energy, nucleotide and fatty acid/glucose metabolites, and survival signaling suggesting a role of host cell metabolism in regulating their intracellular growth (<xref ref-type="bibr" rid="ref12">Caradonna et al., 2013</xref>). Finally, when the host cell is overwhelmed, amastigotes differentiate into trypomastigotes, host cell is lysed, and infective parasites are released to the bloodstream and eventually could access to the CNS.</p>
<p>Extensive clinical, cerebrospinal fluid (CSF), neuroimaging, and neuropathological data support persistent HIV infection in the CNS (<xref ref-type="bibr" rid="ref64">Valcour et al., 2011</xref>). We and others have demonstrated that, like other CNS cells, astrocytes can host several infectious agents, including HIV and <italic>T. cruzi</italic> (<xref ref-type="bibr" rid="ref9">Blanchet et al., 2010</xref>; <xref ref-type="bibr" rid="ref65">Vargas-Zambrano et al., 2013</xref>; <xref ref-type="bibr" rid="ref63">Urquiza et al., 2017</xref>) and are regarded as important performers in Chagasic meningoencephalitis development. HIV can infect the brain and impair CNS function. HIV does not directly infect neurons but causes neuronal damage by affecting microglia and other cells in the CNS including astrocytes, causing primary CNS injury (<xref ref-type="bibr" rid="ref23">Ellis et al., 2009</xref>). This evidence indicated that the cellular response at the local level is altered during HIV infection and the responses to a secondary infection such as <italic>T. cruzi</italic> could be altered favoring the parasite survival and multiplication. Moreover, HIV-infected astrocytes also alter the blood-brain barrier (BBB) permeability due to endothelial cell apoptosis through the disruption of gap junction (<xref ref-type="bibr" rid="ref24">Eugenin et al., 2012</xref>). This bystander BBB toxicity mediated by HIV-infected astrocytes contributes to understanding not only how the CNS damage caused by HIV has spread but also the increased entry of other pathogens to the CNS. Therefore, Chagas disease may be reactivated in the CNS due to HIV-induced immunosuppression.</p>
<p>As an obligatory intracellular parasite and due to the variety of cellular host environments, <italic>T. cruzi</italic> faces several sources of reactive oxygen species (ROS) including ROS produced by its metabolism and ROS generated by the host&#x2019;s immune responses. Paradoxically, besides the role of ROS in pathogen elimination during the oxidative burst, increasing evidence suggests that ROS production is beneficial to <italic>T. cruzi</italic> infection (<xref ref-type="bibr" rid="ref30">Gupta et al., 2009</xref>; <xref ref-type="bibr" rid="ref47">Paiva et al., 2012</xref>, <xref ref-type="bibr" rid="ref48">2018</xref>; <xref ref-type="bibr" rid="ref26">Goes et al., 2016</xref>). This paradoxical role of ROS could be a new target for anti-parasite therapy improvement (<xref ref-type="bibr" rid="ref51">Providello et al., 2018</xref>). During the cellular invasion, trypomastigotes can activate regulatory pathways using a large number of molecules (<xref ref-type="bibr" rid="ref6">Bayer-Santos et al., 2013</xref>) carried by extracellular vesicles (EVs), which are small membrane-bound vesicles able to transport secretome components of <italic>T. cruzi</italic> (<xref ref-type="bibr" rid="ref53">Retana Moreira et al., 2019</xref>). Nevertheless, it remains unclear whether EVs released from parasitized cells and/or by trypomastigotes play any role on <italic>T. cruzi</italic> infection and multiplication by altering the cell host pro-oxidant status.</p>
<p>In the present work, we investigated how the pro-oxidant condition self-promoted by the parasite using its own trypomastigotes derived-EVs or by HIV infection is able to influence <italic>T. cruzi</italic> infection and multiplication in human astrocytes.</p>
</sec>
<sec id="sec2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="sec3">
<title>Astrocyte Cultures and <italic>T. cruzi</italic> Strain</title>
<p>Normal human astrocytes (NHA; Lonza&#x00AE;, Pharma&#x0026;Biotech-Bioscience Solutions) were used. NHA were seeded and grown in AGM&#x2122; Bullet Kit&#x2122; medium (Lonza&#x00AE;) at 37&#x00B0;C with 5% CO<sub>2</sub>.</p>
<p><italic>T. cruzi</italic> K98 clone belonging to the discrete typing unit I (DTU I) was used. The clone K98 of the parasite was genetically modified to express the enhanced green fluorescent protein (eGFP). The parasite depicts a homogeneous pattern of GFP fluorescence that allowed to measure both the infection and the multiplication rate in astrocytes. <italic>T. cruzi</italic> was preserved in monolayers of Vero cells (ECACC 84112001). After being released from infected cells, trypomastigotes were collected from supernatants by low-speed centrifugation (500 rpm, 10 min) in order to remove any contaminating cell debris and then counted in a Neubauer chamber.</p>
</sec>
<sec id="sec4">
<title>HIV env-Pseudotyped Production, Titration, and Infection Efficiency Measurement</title>
<p>The pNL4-3 is a full-length infectious molecular clone of HIV that utilizes CXCR4 as a co-receptor. The NL4-3-GFP and pNL4-3-DsRed are two molecular clones that contain the enhanced version of the green fluorescent protein gene (eGFP) or the <italic>Discosoma</italic> sp. red fluorescent protein (DsRed, Clontech), respectively. These viral clones were used alternatively according to fluorochromes requirements for microscopy or flow cytometry evaluation. High-titer stocks of HIV env-pseudotyped with vesicular stomatitis virus envelope glycoprotein (VSV-G) were obtained by cotransfecting 293T cells with a VSV-G expression plasmid (Clontech) at HIV/VSV-G plasmid ratio of 10:1. The concentration of virus stocks was adjusted to a titer of 100 ng/&#x03BC;l of p24 (HIV capsid protein). Viral infection efficiency was monitored as a function of time using three different approaches: (1) HIV p24 capsid protein in cell culture supernatants (p24 ELISA kit, INNOTEST HIV Antigen mAb), (2) HIV p24 intracellular expression using the KC57 monoclonal antibody labeled with fluorescein isothiocyanate against p24 (p24-FITC) protein (Beckman Coulter, United States; <xref ref-type="bibr" rid="ref14">Chassagne et al., 1986</xref>; <xref ref-type="bibr" rid="ref17">Darden et al., 2000</xref>), and (3) HIV gene expression by GFP or DsRed measurement by flow cytometry (FACSCanto II flow cytometer, BD Biosciences, San Jose, CA, United States). Additionally, the identification of productively infected cells for each pathogen, eventual cohabitation of both and neighbor-uninfected cells in a heterogeneous population was measured using flow cytometry analysis of cell fluorescence, by, allows. The measurement of fluorochrome expression sensitivity and performance were checked before data acquisition using Cytometer Setup &#x0026; Tracking beads (BD Biosciences, San Jose, CA, United States). All experiments were performed in a BSL-3 laboratory at the INBIRS.</p>
</sec>
<sec id="sec5">
<title>HIV and <italic>T. cruzi</italic> Infection of Astrocytes</title>
<p>For infection, human astrocytes were seeded in 48-well culture plates at 3 &#x00D7; 10<sup>4</sup>cells/well. The HIV infection was carried put using an inoculum of 8 &#x03BC;g/ml (measured as p24 antigen), while <italic>T. cruzi</italic> infection with trypomastigotes used a parasite:cell ratio of 5:1. Hence, we used 1.5 &#x00D7; 10<sup>5</sup> trypomastigotes/well. In these conditions, the release of trypomastigotes began 5-day post-exposure (dpe) from <italic>T. cruzi</italic>-infected astrocytes. To ensure the absence of free HIV particles before inoculating the parasite, astrocytes were washed five times with fresh DMEM.</p>
</sec>
<sec id="sec6">
<title>Evaluation of the <italic>T. cruzi</italic> Infection and Multiplication</title>
<p>The level of infection and multiplication of <italic>T. cruzi</italic> in astrocytes were measured by flow cytometry. For debris exclusion, astrocytes were gated based on side scatter and forward scatter. Quantification of astrocytes with specific fluorescence as well as the mean fluorescence intensity (MFI) in those cells was indicative of infection and multiplication efficiency, respectively. We have collected, stored, and analyzed the data from 5 &#x00D7; 10<sup>4</sup> cells using Flow Jo X software for Windows 7.0.</p>
<p><italic>T. cruzi</italic> infection was also evaluated by fluorescence microscopy. The presence of intracellular amastigotes was evaluated using rabbit polyclonal anti-<italic>T. cruzi</italic> antibody (kindly donated by Dr. Federico Penas, INBIRS, Universidad de Buenos Aires, Argentina). Then, a commercial goat anti-rabbit IgG (H &#x002B; L) secondary antibody, Alexa Fluor 647 (Invitrogen, Thermo Fisher) was used. The coverslips mounted with DAPI Fluoromount-G (Southern Biotech) were studied in a Nikon Eclipse Ti-S L100 fluorescence microscope using a Plan Apochromat 60 &#x00D7; 1.42 NA oil immersion objective. Images were analyzed using the NIS-Element software.</p>
<p>Finally, a standardized real-time PCR-based method was carried out to quantify intracellular <italic>T. cruzi</italic> DNA (<xref ref-type="bibr" rid="ref54">Schijman et al., 2011</xref>). For this purpose, after the solvent-based DNA extraction, a Sybr-Green-based real-time PCR targeted to parasite satellite DNA (Sat-DNA) using specific primers TCZ-F (5'-GCTCTTGCCCACAMGGGTGC-3') and TCZ-R (5'-CCAAGCAGCGGATAGTTCAGG-3') was carried out.</p>
</sec>
<sec id="sec7">
<title>Astrocyte Apoptosis Measurement by Flow Cytometry</title>
<p>Using flow cytometry, the percentage of early apoptotic cells was defined based on the plasma membrane permeability and phosphatidylserine cell translocation measurement. For this purpose, dual staining was done with PE or APC-conjugated Annexin-V and 7-amino-actinomycin D (7AAD) using the Annexin-V/7AAD apoptosis detection kit (BD Biosciences).</p>
</sec>
<sec id="sec8">
<title>Isolation, Quantification, and Characterization of Extracellular Vesicles</title>
<p>Free trypomastigotes of <italic>T. cruzi</italic> and human astrocytes were washed with serum-free DMEM. Subsequently, secretion equivalents were obtained from 10<sup>8</sup> parasites and 10<sup>7</sup> astrocytes as was previously described with modifications (<xref ref-type="bibr" rid="ref11">Caeiro et al., 2018</xref>). For this purpose, such parasite and human cells were incubated in DMEM 10% Gibco Exosome-depleted fetal bovine serum (FBS) at 37&#x00B0;C for 6 h in a humidified atmosphere with 5% CO<sub>2</sub>. The products secreted by trypomastigotes and astrocytes were isolated by centrifugation and filtration as follows: (a) 3,000 <italic>g</italic> for 10 min at 4&#x00B0;C to remove the trypomastigotes and apoptotic bodies followed by (b) ultracentrifugation at 100,000 <italic>g</italic> at 4&#x00B0;C to generate the pellet of EVs followed by the second ultracentrifugation with PBS to remove impurities, and finally, (c) the cell-free supernatant was filtered with 0.45 &#x03BC;m syringe filters. The supernatant was wasted, and the exosome pellet was resuspended in 200 &#x03BC;l&#x2013;1 ml PBS for scanning electron microscopy (SEM) inspection. All ultracentrifugation stages were performed in a 70Ti fixed angle rotor in an Optima XL 100 k ultracentrifuge (Beckman Coulter). For each pellet, protein quantification was spectrophotometrically performed using the Bio-Rad Protein Assay reagent and bovine serum albumin (BSA; 1 mg/ml) as standard.</p>
<p>To assess the biochemical characteristics of EVs by Western Blot, 40 &#x03BC;g of EVs isolated from 100 &#x00D7; 10<sup>6</sup> of trypomastigotes obtained in Vero cells, and 10 &#x00D7; 10<sup>6</sup> astrocytes or their equivalent of soluble vesicle secretion (EVs) were electrophoresed in 12% denaturing polyacrylamide gels and transferred to PVDF membranes by standard methodologies. The appropriate transfer was tested by reversible membrane staining with Ponceau Red (5% w/v) in 1% acetic acid (v/v). The membrane was blocked with TBS-3% non-fat milk for 1 h, washed with TBS-0.05% Tween and incubated with primary antibodies. After several washes, membranes were incubated with the secondary antibody horseradish peroxidase-conjugated goat anti-mouse IgG (1&#x2236;4000) and developed with the Supersignal&#x00AE; West Pico Chemiluminescent Substrate (Pierce) according to the manufacturer&#x2019;s instructions. The revealed images were acquired by the MultiDoc-It&#x2122; Imaging System. Western blotting of EVs of <italic>T. cruzi</italic> was carried out using primary mouse antibodies anti-TcTASV-C (Trypomastigote Alanine, Serine and Valine protein from <italic>T. cruzi</italic>; 1/400) and anti-SAPA (Shed Acute-Phase Antigen, a trans-sialidase repetitive domain) kindly provided by Dr. Valeria Tekiel (IIB-INTECH, UNSAM-CONICET, Argentina). Mouse anti-CD9 (clone M-L13; BD Bioscience) and anti-CD63 antibodies (clone H5C6; BD Bioscience) were used for EVs derived from astrocytes. As negative controls, two cytoplasmic proteins were detected: rabbit polyclonal anti-calnexin (1/500; Abcam) and rabbit polyclonal anti-SR62 (1/1000), which must be absent in pure EVs of astrocytes and trypomastigotes, respectively.</p>
<p>For SEM, pellets containing EVs isolated from healthy astrocytes, parasitized cells, and trypomastigotes were vortexed and resuspended in 200 &#x03BC;l&#x2013;1 ml PBS. EVs were fixed in 2% SEM-quality paraformaldehyde aqueous solution and then diluted in distilled water and added in 1&#x2013;5 &#x03BC;l vesicle mixtures to clean silicon chips. Samples were mounted on a SEM stage by carbon paste. SEM (Hitachi S-4700) was performed under low beam energies (5.0&#x2013;10.0 kV). Analysis of EVs sizes was done using the SEM images <italic>via</italic> ImageJ (Wayne Rasband, NIH, United States).</p>
<p>Astrocyte (3 &#x00D7; 10<sup>4</sup> cells/well) stimulation with free <italic>T. cruzi</italic>-derived EVs was performed using 6 &#x03BC;g/well of protein. Such amount of protein was obtained from EVs extracted from 1.5 &#x00D7; 10<sup>5</sup> trypomastigotes. Equal protein concentration was used when challenges were performed with EVs from the other two sources (Tc-infected astrocytes and uninfected astrocytes). The EV-treated astrocytes were exposed to <italic>T. cruzi</italic> at three distinguishable conditions such as 24 h before, simultaneous, or 24 h after EVs exposure.</p>
</sec>
<sec id="sec9">
<title>Detection and Scavenging of Cellular Reactive Oxygen Species Generation</title>
<p>Production of cellular and mitochondrial ROS was evaluated using DCFDA and MitoSOX assays, respectively as follows:</p>
<list list-type="simple">
<list-item><p>a. Cellular ROS production (including hydroxyl, peroxyl, and another ROS) were measured using a DCFDA assay kit (Abcam, United States) according to the manufacturer&#x2019;s protocol. Following a specific timeline after infection, cells were washed twice with PBS, incubated with 25 &#x03BC;M DCFDA in the essential medium at 37&#x00B0;C for 45 min, and evaluated by flow cytometry.</p></list-item>
<list-item><p>b. Cellular mitochondrial ROS measurement by flow cytometry was made by staining with MitoSOX&#x2122; (Thermo Fisher Scientific, United States) following the manufacturer&#x2019;s instructions. Briefly, at the predetermined time points after infection, cells were washed twice with PBS, incubated with 5 &#x03BC;M MitoSOX at the corresponding temperature and time for each reagent, and then evaluated by flow cytometry.</p></list-item>
</list>
<p>Also, astrocytes were pre-treated for 18 h with the antioxidant ascorbic acid (AA) or with MitoTEMPO&#x00AE; (MT; Sigma-Aldrich), a well-known mitochondria-specific superoxide scavenger, to validate the <italic>in vitro</italic> model and to demonstrate ROS functionality. AA is a non-enzymatic antioxidant, contributing to ROS-scavenging. A stock solution of 100 mM (Sigma) was prepared fresh in a modified Krebs buffer and then diluted in cell culture media until 1 mM final concentration. MT was used in a final concentration of 10 &#x03BC;M.</p>
<p>Tert-Butyl hydroperoxide (TBH) is an organic peroxide used as ROS inducer. Here, three serial dilutions were prepared (100, 50, and 10 &#x03BC;M) from a 70% aqueous solution (Sigma-Aldrich). Astrocytes treated with increased concentrations of TBH (1 h, 37&#x00B0;C) were used as positive controls for ROS generation.</p>
</sec>
<sec id="sec10">
<title>Statistical Analysis</title>
<p>Where applicable, statistical analysis was performed. Multiple comparisons between all pairs of groups were made with Tukey&#x2019;s test, and those against two groups were made with Mann-Whitney U test. Graphical and statistical analyses were performed with GraphPad Prism 5.0 software.</p>
<p>Each experiment was performed in triplicates with different culture preparations on five independent occasions. Data were represented as mean &#x00B1; SD measured in triplicate from three individual experiments. A <italic>p</italic> &#x003C; 0.05 is represented as <sup>&#x002A;</sup>, <italic>p</italic> &#x003C; 0.01 as <sup>&#x002A;&#x002A;</sup>, and <italic>p</italic> &#x003C; 0.001 as <sup>&#x002A;&#x002A;&#x002A;</sup>. <italic>p</italic> &#x003C; 0.05 was the minimum level for accepting a statistically significant difference between groups.</p>
</sec>
</sec>
<sec id="sec11" sec-type="results">
<title>Results</title>
<sec id="sec12">
<title><italic>T. cruzi</italic> Induces ROS Upregulation in Astrocytes Favoring Its Infection and Multiplication</title>
<p>During <italic>T. cruzi</italic> infection, the macrophages respiratory burst produces ROS. However, the parasite has an antioxidant machinery to deal with the oxidative burst. Moreover, such pro-oxidant environment fuels the <italic>T. cruzi</italic> infection (<xref ref-type="bibr" rid="ref30">Gupta et al., 2009</xref>; <xref ref-type="bibr" rid="ref47">Paiva et al., 2012</xref>, <xref ref-type="bibr" rid="ref48">2018</xref>; <xref ref-type="bibr" rid="ref26">Goes et al., 2016</xref>). Here, we have examined whether ROS production occurs during the parasite infection of astrocytes and the impact on its multiplication. For this goal, we performed experiments using MitoSOX and DCFDA, useful for measurement of mitochondrial ROS (mROS) and cellular ROS (cROS) activity by flow cytometry, respectively. Twenty-four hours after <italic>T. cruzi</italic> (trypomastigotes) challenge (<xref rid="fig1" ref-type="fig">Figure 1A</xref>), significantly higher mitochondrial and cellular ROS positive cells were measured in infected astrocytes to control cells (<xref rid="fig1" ref-type="fig">Figures 1B</xref>,<xref rid="fig1" ref-type="fig">C</xref>). However, these higher levels of ROS observed after <italic>T. cruzi</italic> exposure did not modify the level of programed cell death in comparison with control astrocytes (<xref rid="fig1" ref-type="fig">Figure 1D</xref>).</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Effect of <italic>Trypanosoma cruzi</italic> infection on astrocyte ROS level and its consequences on parasite infection and multiplication. <bold>(A)</bold> Timeline of the Tc infection of cultured human astrocytes. Parameters were measured at T1 (orange arrow, 24 h after Tc exposure). <bold>(B)</bold> mROS level was measured by flow cytometry using MitoSOX in uninfected astrocytes &#x2013; Ctrl &#x2013; and Tc-infected astrocytes. <bold>(C)</bold> cROS level was measured by flow cytometry using DCFDA (assumed to be proportional to the concentration of hydrogen peroxide) in uninfected astrocytes &#x2013; Ctrl &#x2013; and Tc-infected astrocytes. <bold>(D)</bold> Cell death levels (positive staining for annexin-V and 7-AAD) in uninfected (Ctrl) and Tc-infected astrocytes analyzed by flow cytometry. <bold>(E)</bold> Timeline of the exposure of cultured astrocytes to tert-Butyl hydroperoxide (TBH; blue arrow) followed by Tc infection (green arrow, 1 h after TBH-exposure). Parameters were measured at T3 (orange arrow, 48 h after Tc exposure). <bold>(F)</bold> Cell death levels by flow cytometry (positive staining for annexin-V and 7-AAD) in unexposed (Ctrl) and TBH-exposed cells (at increasing concentrations as indicated), in non-infected (black columns) and Tc-infected (gray columns) astrocytes. <bold>(G)</bold> Tc-infection rate analysis in unexposed (Ctrl) and TBH-exposed cells (at increasing concentrations as indicated). Three representative dot plots representation are shown. For each diagram, a square depicted the percentage of Tc-infected cells (GFP-positive). <bold>(H)</bold> Tc-multiplication quantification by flow cytometry as mean fluorescence intensity (MFI, expressed in arbitrary units) in unexposed (Ctrl) and TBH-exposed cells (at increasing concentrations as indicated). <bold>(I)</bold> Timeline of the exposure of cultured astrocytes to ROS scavengers (MT: MitoTEMPO; AA: ascorbic acid; blue arrow) followed by Tc infection (green arrow, 18 h after scavengers exposure). Parameters were measured at T3 (orange arrow, 48 h after Tc exposure). <bold>(J)</bold> Tc-infection rate analysis in non-scavenged and scavenged (with MT, or AA) <italic>T. cruzi</italic>-infected cells. <bold>(K)</bold> Tc-multiplication quantification by flow cytometry as MFI in non-scavenged and scavenged (with MT, or AA) <italic>T. cruzi</italic>-infected cells. <bold>(L)</bold> Timeline of the exposure of cultured astrocytes to pro-oxidant condition (TBH, 100 &#x03BC;M during 1 h), ROS scavenging (AA: ascorbic acid), and Tc infection (green arrow, 18 h after AA exposure). Parameters were measured at T3 (orange arrow, 48 h after Tc exposure). <bold>(M)</bold> Astrocyte ROS level (% cell DCFDA&#x002B;) and Tc infection rate (% cell Tc&#x002B;) analysis in control and TBH-treated astrocytes, with and without scavenging (AA). Graphics are showing values obtained from three independent experiments. Data are given as the mean &#x00B1; SD. NS (not significant), <sup>&#x002A;</sup><italic>p</italic> &#x003C; 0.05, <sup>&#x002A;&#x002A;</sup><italic>p</italic> &#x003C; 0.01, and <sup>&#x002A;&#x002A;&#x002A;</sup><italic>p</italic> &#x003C; 0.001.</p>
</caption>
<graphic xlink:href="fmicb-11-563320-g001.tif"/>
</fig>
<p>Furthermore, to evaluate the ROS impact on <italic>T. cruzi</italic> infection and multiplication, astrocytes were treated with 10, 50, and 100 &#x03BC;M TBH for 1 h before being exposed to trypomastigotes (<xref rid="fig1" ref-type="fig">Figure 1E</xref>). The level of cell death was evaluated after 48 h in both conditions: control cells (only exposed to TBH) and TBH/<italic>T. cruzi</italic>-infected cells.</p>
<p>In uninfected cells, the level of cell death after TBH treatment did not depict any significant differences according to growing (10, 50, and 100 &#x03BC;M) pro-oxidant concentration respect to untreated control. But the level of cell death on astrocytes was significantly higher in <italic>T. cruzi</italic>-infected cells in the presence of 50 and 100 &#x03BC;M of TBH as shown in <xref rid="fig1" ref-type="fig">Figure 1F</xref>.</p>
<p>The impact of TBH-induced pro-oxidant level on <italic>T. cruzi</italic> infection and multiplication was measured 48 h post-parasite exposure. The infection rate of astrocytes by <italic>T. cruzi</italic> was directly and dose-dependently influenced by the level of ROS. Cells exposed to growing doses of TBH (10, 50, and 100 &#x03BC;M) showed significantly higher levels of infection compared to unexposed controls (<xref rid="fig1" ref-type="fig">Figure 1G</xref>). Likewise, a significantly higher level of amastigote multiplication was found when astrocytes were under pro-oxidant condition maintaining a dose-dependent response according to increased TBH level in comparison with unexposed controls (<xref rid="fig1" ref-type="fig">Figure 1H</xref>).</p>
<p>The incumbency of the pro-oxidant environment on <italic>T. cruzi</italic> infection and multiplication was also evaluated by diminishing the ROS activity using mitochondrial and cytoplasmic scavengers (MT and AA, respectively) before parasite infection (<xref rid="fig1" ref-type="fig">Figure 1I</xref>). When the ROS level was depleted using scavengers, significantly lower infection and multiplication were observed (<xref rid="fig1" ref-type="fig">Figures 1J</xref>,<xref rid="fig1" ref-type="fig">K</xref>). Finally, the influence of both, the TBH-pro-oxidant environment (using 100 &#x03BC;M) and the ROS scavenging (using AA) on both <italic>T. cruzi</italic> infection rate and ROS level (measured using DCFDA) were simultaneously measured. Thus, the parasite infection rate and the ROS level among astrocytes previously exposed to TBH were significantly higher than control (non-TBH exposed) cells. Although, when ROS scavenging with AA was applied on astrocytes (initially exposed or not to TBH) after their parasite challenge both, Tc infection rate and ROS level appeared significantly reduced (<xref rid="fig1" ref-type="fig">Figures 1L</xref>,<xref rid="fig1" ref-type="fig">M</xref>).</p>
<p>Taken together, our results indicate that astrocytes primed by an oxidative environment or by their oxidative stress &#x2013; with cellular and mitochondrial ROS production &#x2013; enhance their <italic>T. cruzi</italic> infection and multiplication.</p>
</sec>
<sec id="sec13">
<title>Extracellular Vesicles Enhance <italic>T. cruzi</italic> Infection by Inducing ROS Upregulation</title>
<p>Considering their role in parasitism increment (<xref ref-type="bibr" rid="ref53">Retana Moreira et al., 2019</xref>), the capability of EVs released from <italic>T. cruzi</italic> to alter the host-cell oxidant environment was evaluated. EVs were obtained after incubation of 10 &#x00D7; 10<sup>7</sup> parasite tissue-culture cell-derived trypomastigotes (K98 strain). These EVs were characterized by Scanning Electronic Microscopy (SEM), and the presence of <italic>T. cruzi</italic> trypomastigotes surface molecules (SAPA and Tc-TASV-C antigens) was assessed by western blotting (<xref rid="fig2" ref-type="fig">Figures 2A</xref>,<xref rid="fig2" ref-type="fig">B</xref>). Besides, EVs obtained from 10 &#x00D7; 10<sup>6</sup> astrocytes parasitized by <italic>T. cruzi</italic> amastigotes as well as from non-infected astrocytes. These EVs were biochemically characterized by detecting cell-derived EVs canonical proteins CD9 and CD63 (<xref rid="fig2" ref-type="fig">Figure 2C</xref>).</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>Effect of trypomastigotes-derived extracellular vesicles (EVs) in astrocytes ROS concentration and <italic>Trypanosoma cruzi</italic> infection. <bold>(A)</bold> Scanning electron microscopy (SEM) showing clusters of trypomastigotes-derived EVs formed by ultracentrifugation. The bar size is indicated. <bold>(B)</bold> Biochemical characterization of EVs purified from trypomastigotes by western blot to verify the presence of SAPA (shed acute-phase antigen) and Tc-TASV-C antigens and the absence of SR62 (<italic>T. cruzi</italic> cytoplasmic antigen). <bold>(C)</bold> Biochemical characterization of EVs purified from astrocytes. The presence of CD63, CD9, and absence of calnexin was determined by western blot from astrocyte-derived EVs. <bold>(D)</bold> Timeline of the EVs exposure (blue arrow) in cultured astrocytes followed by Tc infection (green arrow, 24 h after EVs exposure). Parameters were measured at T3 (orange arrow, 48 h after Tc exposure). <bold>(E)</bold> Tc-infection rate measured as GFP&#x002B; cells analysis in EVs non-exposed astrocytes followed by Tc infection (Tc), and EVs-exposed cells [EVs from normal astrocytes (EVs A), Tc-infected astrocytes (EVs A/Tc), and EVs from free trypomastigotes (EVs Tc)]. Two representative dot plots obtained by flow cytometry showing EVs non-exposed astrocytes (Ctrl, left panel) and EVs (from trypomastigotes) exposed-astrocytes (EVs-Tc, right panel). In each diagram, a square depicted the percentage of Tc-infected cells (GFP-positive). <bold>(F)</bold> Astrocyte death levels (measured as positive staining for annexin-V and 7-AAD) in EVs non-exposed astrocytes followed by Tc infection (Ctrl), and EVs-exposed cells [with EVs obtained from cell sources defined in item <bold>(E)</bold>]. <bold>(G)</bold> Tc-infection rate measured as GFP&#x002B; cells analysis in EVs from free trypomastigotes (EVs Tc) at dilutions 1/100 (0.06 &#x03BC;g/well), 1/10 (0.6 &#x03BC;g/well), and pure (6 &#x03BC;/well). <bold>(H)</bold> Cellular and mitochondrial ROS level (using DCFDA &#x2013; represented in gray columns and MitoTEMPO &#x2013; represented in black columns, respectively) as MFI, in astrocytes (exposed to EVs from sources described in <bold>E</bold>). <bold>(I)</bold> Timeline of the EVs exposure (blue arrow) in cultured astrocytes simultaneously infected with Tc (green arrow). Parameters were measured at T2 (orange arrow, 48 h after Tc &#x002B; EVs exposure). <bold>(J)</bold> Timeline of the cultured astrocytes infected with Tc (green arrow) and stimulated with EVs (blue arrow, 24 h after Tc exposure). Parameters were measured at T3 (orange arrow, 48 h after EVs exposure). <bold>(K)</bold> Tc-infection rate measured as GFP&#x002B; cells analysis in EVs non-exposed astrocytes but Tc-infected (Ctrl), and EVs from free trypomastigotes-exposed cells simultaneously with Tc infection. <bold>(L)</bold> Tc-infection rate measured as GFP&#x002B; cells in EVs non-exposed astrocytes but Tc-infected (Ctrl), and EVs from free trypomastigotes-exposed cells after infection with Tc. Graphics are showing values obtained from three independent experiments. Data are given as the mean &#x00B1; SD Significant differences are indicated by <sup>&#x002A;</sup><italic>p</italic> &#x003C; 0.05, <sup>&#x002A;&#x002A;</sup><italic>p</italic> &#x003C; 0.01, and <sup>&#x002A;&#x002A;&#x002A;</sup><italic>p</italic> &#x003C; 0.001, respectively.</p>
</caption>
<graphic xlink:href="fmicb-11-563320-g002.tif"/>
</fig>
<p>When astrocytes were exposed to EVs released by free trypomastigotes (but not from EVs released from Tc-infected cells and EVs from uninfected cells) during 24 h, a significant increase in the ROS level was observed respect to untreated cells. The influence of this EVs-induced oxidant environment on the <italic>T. cruzi</italic> infection rate was evaluated following an analogous timeline than previous ones (<xref rid="fig2" ref-type="fig">Figure 2D</xref>). In this condition, the infection rate was increased significantly without infringing significant changes in cell viability (<xref rid="fig2" ref-type="fig">Figures 2E</xref>,<xref rid="fig2" ref-type="fig">F</xref>). This EVs-mediated parasitism augmentation phenomenon showed a dose-dependence since it was significantly reduced when exposures were carried out with 1/10 and 1/100 dilutions of EVs (0.6 and 0.06 &#x03BC;g/well, respectively; <xref rid="fig2" ref-type="fig">Figure 2G</xref>). The ROS (cellular and mitochondrial) level in astrocytes exposed to trypomastigotes-derived EVs was significantly higher than control cells. In contrast, such ROS levels in astrocytes did not experience any change after exposure to EVs released from uninfected and parasitized astrocytes (<xref rid="fig2" ref-type="fig">Figure 2H</xref>).</p>
<p>To determine whether the EVs-induced <italic>T. cruzi</italic> infection enhancement keeps a time-dependence, we have evaluated two additional conditions as follows: (i) simultaneous challenge of astrocytes with trypomastigotes-derived EVs and <italic>T. cruzi</italic> (<xref rid="fig2" ref-type="fig">Figure 2I</xref>) and (ii) astrocytes exposure to free trypomastigotes-derived EVs after their <italic>T. cruzi</italic> exposure (<xref rid="fig2" ref-type="fig">Figure 2J</xref>). In both conditions, the <italic>T. cruzi</italic> infection rate did not differ significantly from control cells (<xref rid="fig2" ref-type="fig">Figures 2K</xref>,<xref rid="fig2" ref-type="fig">L</xref>, respectively). Likewise, the ROS level was similar in these two conditions (data not shown).</p>
<p>Taken together, these results demonstrate that EVs from free <italic>T. cruzi</italic> trypomastigotes prime astrocytes by raising their ROS level, thus enhancing the parasite infection and multiplication.</p>
</sec>
<sec id="sec14">
<title><italic>T. cruzi</italic> Infection and Multiplication in Astrocytes Is Enhanced by HIV Infection</title>
<p>We and others have demonstrated that astrocytes can be productively infected by HIV (<xref ref-type="bibr" rid="ref5">Barat et al., 2018</xref>; <xref ref-type="bibr" rid="ref45">Ojeda et al., 2018</xref>; <xref ref-type="bibr" rid="ref39">Li et al., 2020</xref>) and when <italic>T. cruzi</italic> is concomitantly present, both pathogens may interact (<xref ref-type="bibr" rid="ref63">Urquiza et al., 2017</xref>). To assess the influence of HIV infection of astrocytes on its posterior <italic>T. cruzi</italic> superinfection and multiplication, primary cultured human astrocytes were exposed subsequently to both pathogens (<xref rid="fig3" ref-type="fig">Figure 3A</xref>). The parasite infection and multiplication were evaluated 24 h after <italic>T. cruzi</italic> exposure. The rate of parasitism was increased significantly when astrocytes were previously exposed to HIV in comparison with those non-exposed to HIV as shown in <xref rid="fig3" ref-type="fig">Figure 3B</xref>. Also, the multiplication of <italic>T. cruzi</italic> in astrocytes was also significantly enhanced (<xref rid="fig3" ref-type="fig">Figures 3C</xref>,<xref rid="fig3" ref-type="fig">D</xref>). HIV enhancement of parasite multiplication was also detected by quantifying amastigotes microsatellite DNA sequence (TCZ) using real-time PCR (<xref rid="fig3" ref-type="fig">Figure 3E</xref>). Furthermore, using both flow cytometry analysis and immunofluorescence microscopy, we coincidentally observed that after challenging astrocytes with both pathogens, monoinfected cells were the most abundant, while the HIV/<italic>T. cruzi</italic> coinfected astrocytes were found to a lesser extent (<xref rid="fig3" ref-type="fig">Figures 3F</xref>&#x2013;<xref rid="fig3" ref-type="fig">H</xref>). Taken together, these observations pointed out that a previous HIV infection of astrocytes increases their subsequent infection by <italic>T. cruzi</italic> as well as parasite multiplication, without implying the intracellular cohabitation of both pathogens as <italic>sine-qua-non</italic> condition.</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>Effect of HIV infection of astrocytes on <italic>Trypanosoma cruzi</italic> infection and multiplication. <bold>(A)</bold> Timeline of the HIV (T0, blue arrow) and Tc (T2 green arrow, after 48 h of HIV exposure) infection of cultured human astrocytes. Parameters were measured at T3 (orange arrow, 24 h after Tc exposure). <bold>(B)</bold> Effect of HIV pre-infection of astrocytes on the Tc-infection rate measured by flow cytometry analysis as percentages of GFP&#x002B; cells. <bold>(C)</bold> Histogram example of the quantitative analysis of Tc-GFP positive cells proportion and MFI measured by flow cytometry. The <italic>x</italic>-axis represents the fluorescent signal intensity, and <italic>y</italic>-axis the normalized cell number expressed as a percentage of the maximum. <bold>(D)</bold> Relationship between the geometric mean of MFI of Tc-GFP positive cells in Tc infection (Tc), and astrocytes infected by HIV and superinfected by Tc (HIV/Tc). <bold>(E)</bold> Measurement of variation in the Tc DNA level (as fold change) by qPCR in astrocytes only infected by Tc (Tc), and in astrocytes infected by HIV at first and superinfected by Tc (HIV/Tc). <bold>(F)</bold> Measurement by flow cytometry of HIV (black), Tc (dark gray), and HIV &#x002B; Tc (light gray)-infected astrocytes by determining the frequencies of HIV-GFP&#x002B;, Tc-DsRED&#x002B;, and HIV-GFP&#x002B;/Tc-DsRED&#x002B; cells. <bold>(G)</bold> A representative dot plot diagram obtained by flow cytometry during Tc and/or HIV infection quantification of cultured astrocytes is shown. <bold>(H)</bold> Fluorescence microscopy showing Tc (Red: K98-Alexa fluor 647-labeled intracellular amastigotes) and/or HIV (Green: p24 FITC-labeled) infected-primary human astrocytes. Cell and parasite nucleus were stained by DAPI (blue). Graphics are showing values obtained from three independent experiments. Data are given as the mean &#x00B1; SD Significant differences are indicated by <sup>&#x002A;</sup><italic>p</italic> &#x003C; 0.05, <sup>&#x002A;&#x002A;</sup><italic>p</italic> &#x003C; 0.01, and <sup>&#x002A;&#x002A;&#x002A;</sup><italic>p</italic> &#x003C; 0.001, respectively.</p></caption>
<graphic xlink:href="fmicb-11-563320-g003.tif"/>
</fig>
</sec>
<sec id="sec15">
<title>Intracellular HIV-Induced ROS Contributes to Increasing <italic>T. cruzi</italic> Infection and Multiplication in Astrocytes</title>
<p>Recently, we have reported that HIV infection increases ROS generation in astrocytes (<xref ref-type="bibr" rid="ref45">Ojeda et al., 2018</xref>). Resembling the HIV-mediated enhancement of <italic>T. cruzi</italic> infection described above, we were prompted to study whether HIV-induced ROS production on astrocytes is a dose-dependent phenomenon that may influence susceptibility to <italic>T. cruzi</italic> infection and multiplication (<xref rid="fig4" ref-type="fig">Figure 4A</xref>). For this goal, astrocytes were challenged with two inoculums of HIV: 8 and 80 &#x03BC;g/ml, thus increasing both the rate of HIV infection and the astrocyte ROS level (<xref rid="fig4" ref-type="fig">Figure 4B</xref>). After the challenge with <italic>T. cruzi</italic>, these astrocytes exhibiting significantly increased <italic>T. cruzi</italic> infection and multiplication (<xref rid="fig4" ref-type="fig">Figures 4C</xref>,<xref rid="fig4" ref-type="fig">D</xref>). When HIV infection of astrocytes was followed by scavenger treatment before <italic>T. cruzi</italic> exposure (<xref rid="fig4" ref-type="fig">Figure 4E</xref>), the level of parasitism was even significantly lower than untreated cells (<xref rid="fig4" ref-type="fig">Figure 4F</xref>).</p>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption>
<p>Role of HIV-induced ROS on <italic>Trypanosoma cruzi</italic> infection and multiplication in astrocytes. <bold>(A)</bold> Timeline of the HIV exposure (blue arrow) of cultured astrocytes followed by Tc infection (green arrow, 48 h after HIV exposure). Parameters were measured at T3 (orange arrow, 24 h after Tc exposure). <bold>(B)</bold> Cellular ROS levels (as a percentage of DCFDA-positive cells, on left y-axis) and HIV infection efficiency (measured by flow cytometry as a percentage of GFP-positive cells, on the right y-axis) using two different inoculums at T0 (&#x002B;: 8 &#x03BC;g/ml, &#x002B;&#x002B;: 80 &#x03BC;g/ml of p24 antigen). <bold>(C)</bold> Tc-infection rate measured by flow cytometry analysis in HIV non-exposed (Tc) and HIV-exposed cells (at the two inoculums indicated as HIV&#x002B;/Tc and HIV&#x002B;&#x002B;/Tc). <bold>(D)</bold> Tc-multiplication quantification by flow cytometry as mean fluorescence intensity (MFI, expressed in arbitrary units) in HIV non-exposed (Tc) and HIV-exposed astrocytes (at the two inoculums indicated as HIV&#x002B;/Tc and HIV&#x002B;&#x002B;/Tc). <bold>(E)</bold> Timeline of the HIV exposure (blue arrow) of cultured astrocytes followed by scavenging (MT: MitoTEMPO; AA: ascorbic acid; violet arrow, 24 h after HIV exposure), and Tc infection (green arrow, 48 h after HIV exposure). Parameters were measured at T3 (orange arrow, 24 h after Tc exposure). <bold>(F)</bold> Tc-infection rate measured by flow cytometry analysis in HIV non-exposed astrocytes followed by Tc infection (Tc) and in HIV-exposed cells (at the two inoculums as indicated), then scavenged (with MT, or AA), and finally exposed to Tc. A control without pretreatment with scavengers is included (HIV &#x002B; Tc). Graphics are showing values obtained from three independent experiments. Data are given as the mean &#x00B1; SD Significant differences are indicated by <sup>&#x002A;</sup><italic>p</italic> &#x003C; 0.05, <sup>&#x002A;&#x002A;</sup><italic>p</italic> &#x003C; 0.01, and <sup>&#x002A;&#x002A;&#x002A;</sup><italic>p</italic> &#x003C; 0.001, respectively.</p></caption>
<graphic xlink:href="fmicb-11-563320-g004.tif"/>
</fig>
<p>Taken together, these results demonstrate that infection and multiplication of <italic>T. cruzi</italic> in astrocytes increase when cells are previously exposed to HIV, since this raises ROS activity.</p>
</sec>
</sec>
<sec id="sec16" sec-type="discussions">
<title>Discussion</title>
<p>In immunosuppression conditions, the reactivation of <italic>T. cruzi</italic> infection occurs mainly in the CNS. In this context, neurological involvement is observed is the vast majority of HIV-coinfected patients (<xref ref-type="bibr" rid="ref25">Ferreira et al., 1997</xref>; <xref ref-type="bibr" rid="ref16">Cordova et al., 2008</xref>). Astrocytes have been proposed as parasite (<xref ref-type="bibr" rid="ref67">Weinkauf et al., 2011</xref>; <xref ref-type="bibr" rid="ref58">Silva et al., 2015</xref>, <xref ref-type="bibr" rid="ref57">2017</xref>), and also HIV target cells, as we and others have reported (<xref ref-type="bibr" rid="ref63">Urquiza et al., 2017</xref>; <xref ref-type="bibr" rid="ref15">Chen et al., 2020</xref>; <xref ref-type="bibr" rid="ref39">Li et al., 2020</xref>; <xref ref-type="bibr" rid="ref50">Proust et al., 2020</xref>).</p>
<p>The ROS are paradigmatically assumed as antimicrobial defense weapons exhibited by phagocytes. It can be generated using both enzymatically and non enzymatically processes being those that occur into the mitochondria one of the main contributors (<xref ref-type="bibr" rid="ref44">Nathan et al., 1979</xref>). In the CNS, in addition to microglial cells, the activated astrocytes are also source of ROS production (<xref ref-type="bibr" rid="ref55">Sharma et al., 2007</xref>; <xref ref-type="bibr" rid="ref70">Williams et al., 2010</xref>; <xref ref-type="bibr" rid="ref56">Sheng et al., 2013</xref>). Under normal conditions, the ROS produced can be maintained in homeostasis without triggering deleterious effects to the cell host by the coordinated action of antioxidant enzymes and molecules. However, under inflammation among other pathological scenarios, ROS can damage cells (<xref ref-type="bibr" rid="ref56">Sheng et al., 2013</xref>).</p>
<p>Trypomastigotes can actively infect a variety of non-immune and immune cells and also may be phagocytosed by macrophages (<xref ref-type="bibr" rid="ref66">Walker et al., 2014</xref>). Such event activates a rapid increased in the production of inflammatory cytokines (<xref ref-type="bibr" rid="ref37">Koo et al., 2018</xref>), and concomitantly, inducible NADPH oxidase (NOX2) produces superoxide that can be transformed suddenly or enzymatically by superoxide dismutases to H<sub>2</sub>O<sub>2</sub>, which is also dismutated by cytosolic glutathione peroxidase and peroxidase (<xref ref-type="bibr" rid="ref31">Gupta et al., 2011</xref>). Likewise, inducible nitric oxide synthetase (iNOS) produces NO that can react with superoxide and generate peroxynitrite in infected macrophages. Therefore, <italic>T. cruzi</italic> is regularly exposed to ROS throughout its life cycle and needs to effectively manage the antioxidant and reparation systems to overwhelm the toxic effects of oxidative stress. To this goal, this parasite expresses antioxidant enzymes that are crucial to defending against oxidative damage, allowing the parasite to surpass such oxidative conditions (<xref ref-type="bibr" rid="ref47">Paiva et al., 2012</xref>; <xref ref-type="bibr" rid="ref26">Goes et al., 2016</xref>; <xref ref-type="bibr" rid="ref33">Hugo et al., 2017</xref>). Nevertheless, <italic>T. cruzi</italic> produces its own metabolism-derived ROS, and during the intracellular stages of the lifecycle, it must deal with ROS from the host cell oxidative stress. Thus, for its survival <italic>T. cruzi</italic> has developed ROS detoxification and DNA repair pathways (<xref ref-type="bibr" rid="ref43">Mesias et al., 2019</xref>). Moreover, recent evidence indicates that the amastigotes division in macrophages and cardiomyocytes is stimulated in ROS enriched oxidative environments by increasing iron availability from host&#x2019;s cellular reservoir (<xref ref-type="bibr" rid="ref30">Gupta et al., 2009</xref>; <xref ref-type="bibr" rid="ref47">Paiva et al., 2012</xref>, <xref ref-type="bibr" rid="ref48">2018</xref>; <xref ref-type="bibr" rid="ref26">Goes et al., 2016</xref>; <xref ref-type="bibr" rid="ref21">Dias et al., 2017</xref>). Almost all cells need iron as an essential micronutrient, operating as a cofactor for multiple metabolic enzymes. <italic>T. cruzi</italic> demands a large quantity of iron for growth and differentiation (<xref ref-type="bibr" rid="ref22">Dick et al., 2020</xref>). When macrophages are exposed antioxidants, then the availability of iron decreased and provokes a higher expression of ferritin (a protein that binds iron) and ferroportin-1 (a channel for iron efflux). A low iron level correlates with a lower parasite cargo. Consequently, the use of an iron chelator such as desferrioxamine has been reported to be useful for reducing parasitemia and mortality in experimentally infected mice (<xref ref-type="bibr" rid="ref4">Arantes et al., 2007</xref>). Besides, the HIV replication maybe also influenced when the iron is accumulated or depleted, free radical synthesis is promoted, and inflammation and mitophagy is enhanced (<xref ref-type="bibr" rid="ref2">Allen et al., 2013</xref>; <xref ref-type="bibr" rid="ref3">Andersen et al., 2014</xref>). In the CNS, it was insinuated that an HIV-associated dysregulation of iron transport in the brain may occur, including the possibility of iron deficiency in neurons and iron overload in astrocytes (<xref ref-type="bibr" rid="ref42">Mehta et al., 2017</xref>). However, it is still unknown the iron role on <italic>T. cruzi</italic> life cycle in astrocytes. Thus, mechanisms by which ROS promote <italic>T. cruzi</italic> infection are still to be fully explained. Current speculation sustains that two possible evolutionary and interacting pressures that forced the selection of <italic>T. cruzi</italic> proliferative response are the increased availability of micronutrients (such as labile iron) and the decreased activation of efficient microbicide mechanisms under oxidative stress (<xref ref-type="bibr" rid="ref48">Paiva et al., 2018</xref>). Several research groups have explored the possibility that the oxidative environment is itself a direct stimulus to the growth of <italic>T. cruzi</italic>. As an example, trypomastigotes responded to incubation with H<sub>2</sub>O<sub>2</sub> before the infection, giving rise to greater amastigote cargo after they invaded macrophages or fibroblasts (<xref ref-type="bibr" rid="ref1">Aguiar et al., 2013</xref>). Likewise, cruzipain is a parasite enzyme that increases the susceptibility of macrophages to parasite infection (<xref ref-type="bibr" rid="ref61">Stempin et al., 2008</xref>) and is a major inducer of NOX2 activation during macrophage infection (<xref ref-type="bibr" rid="ref29">Guinazu et al., 2010</xref>).</p>
<p>Astrocytes are the most abundant in a location, where the parasite frequently reactivates in immunocompromised patients, as those with AIDS. Here, we demonstrate that ROS produced by astrocyte during parasite infection also fuels significatively its infection and multiplication. Likewise, as the production of mitochondrial ROS can be potentiated by exogenous oxidants (<xref ref-type="bibr" rid="ref35">Jou, 2008</xref>), we have used an exogenous source of peroxide (TBH) to promote such enhancement. We observed a pronounced augment in the levels of infection and multiplication of the parasite in a concentration-dependent manner. Thus, with the highest concentrations of the pro-oxidant agent, a significant accumulation of amastigotes was observed that may correlate with the increased astrocyte death observed, as occurs among cardiomyocytes at later stages of parasite multiplication (<xref ref-type="bibr" rid="ref18">de Souza et al., 2010</xref>; <xref ref-type="bibr" rid="ref41">Manque et al., 2011</xref>). Furthermore, such ROS-dependent exacerbation of the <italic>T. cruzi</italic> infection and multiplication in astrocytes was counteracted when mitochondrial and cellular ROS were scavenged. Likewise, similar findings were reported in macrophages. The incubation of infected macrophages with up to 100 &#x03BC;M H<sub>2</sub>O<sub>2</sub> promotes a more intensive amastigote proliferation, but the concentrations of H<sub>2</sub>O<sub>2</sub> that reach the cytosol are unknown. During the macrophage respiratory burst, the cytosolic concentration of H<sub>2</sub>O<sub>2</sub> would be around 1&#x2013;4 &#x03BC;M (<xref ref-type="bibr" rid="ref47">Paiva et al., 2012</xref>). We have observed that astrocytes viability at concentrations of TBH higher than 250 &#x03BC;M was lower than 10% (data not shown). Nevertheless, a concentration of H<sub>2</sub>O<sub>2</sub> as high as 300 &#x03BC;M is unlikely to occur <italic>in vivo</italic> (<xref ref-type="bibr" rid="ref32">Huang and Sikes, 2014</xref>).</p>
<p>Remarkably, other cell types present in the intact CNS could contribute to the regulation of oxidative state experienced by astrocytes. Hence, the progression of HIV infection toward more advanced stages is accompanied by iron accumulation on macrophages and, at the CNS, microglia. The iron excess may enhance the oxidative stress which impairs immune mechanisms. As well, microglial cells are also susceptible to be infected by this parasite, thus generating another cellular scenario for cohabitation. However, astrocytes appear to be more permissive to parasite replication because the activation of the NLRP3 inflammasomes is lower than in microglia-infected cells (<xref ref-type="bibr" rid="ref46">Pacheco et al., 2019</xref>).</p>
<p>Astrocytes are host-cells for both pathogens (<xref ref-type="bibr" rid="ref9">Blanchet et al., 2010</xref>; <xref ref-type="bibr" rid="ref65">Vargas-Zambrano et al., 2013</xref>; <xref ref-type="bibr" rid="ref63">Urquiza et al., 2017</xref>). Then, in a coinfection &#x2013; with cellular cohabitation or by bystander effect between monoinfected cells &#x2013; the progress of the infections can be modified. Such cell-to-cell interactions may involve the participation of EVs, as was reported for <italic>T. cruzi</italic> parasitized cells (<xref ref-type="bibr" rid="ref28">Goncalves et al., 1991</xref>; <xref ref-type="bibr" rid="ref62">Trocoli Torrecilhas et al., 2009</xref>). The interaction between <italic>T. cruzi</italic> released EVs and target cells may modulate the host responses against the parasite (<xref ref-type="bibr" rid="ref13">Cestari et al., 2012</xref>; <xref ref-type="bibr" rid="ref52">Ramirez et al., 2017</xref>). Similarly, EVs obtained from <italic>T. cruzi</italic> tissue-culture cell-derived trypomastigotes promote functional changes in host-target cells that enhance its infection (<xref ref-type="bibr" rid="ref53">Retana Moreira et al., 2019</xref>), as well as to modulate the host immune response in favor of the parasite and carry different virulence factors (<xref ref-type="bibr" rid="ref52">Ramirez et al., 2017</xref>; <xref ref-type="bibr" rid="ref11">Caeiro et al., 2018</xref>; <xref ref-type="bibr" rid="ref40">Lovo-Martins et al., 2018</xref>). In line with these reports, we were able to demonstrate that EVs from free trypomastigotes, but not from intracellular amastigotes, were able to increase the host cellular and mitochondrial ROS level which consequently enhanced <italic>T. cruzi</italic> infection in astrocytes, in a concentration-dependent manner. Therefore, this EVs released by the parasite can contain enzymes that increase the ROS production after inducing cell host NADPH oxidase activity (<xref ref-type="bibr" rid="ref29">Guinazu et al., 2010</xref>), thus increasing the susceptibility to infection (<xref ref-type="bibr" rid="ref61">Stempin et al., 2008</xref>). Moreover, under pro-oxidant conditions, EVs shedding is induced (<xref ref-type="bibr" rid="ref7">Benedikter et al., 2018</xref>), which also may carry different antioxidant enzymes involved in ROS scavenging (<xref ref-type="bibr" rid="ref10">Bodega et al., 2019</xref>).</p>
<p>We have previously reported that HIV infection increases intracellular ROS levels in astrocytes. Such oxidative stress was observed among productively and non-productively infected cells, as a bystander effect. Nevertheless, the astrocytes productively infected with HIV but not the non-productively infected ones were able to mitigate ROS production. So, intracellular ROS concentration remained high among non-productive HIV infected cells (<xref ref-type="bibr" rid="ref45">Ojeda et al., 2018</xref>) as a consequence of its diffusion through channels in the plasma membrane, or promoted by soluble HIV-released proteins released from infected cells (<xref ref-type="bibr" rid="ref60">Song et al., 2007</xref>). This cellular scenario allows explaining the very low frequency of astrocytes with intracellular coexistence of both pathogens observed in the present study, emphasizing that the synergic interplay between both pathogens may dispense with the intracellular cohabitation.</p>
<p>Currently, the genotypes of <italic>T. cruzi</italic> are assembled in seven discrete typing units (<xref ref-type="bibr" rid="ref34">Jansen et al., 2020</xref>). It was documented an increased production of ROS and the resulting oxidative damage during both acute and chronic stages of <italic>T. cruzi</italic> infection with strains from different DTUs (<xref ref-type="bibr" rid="ref68">Wen et al., 2010</xref>, <xref ref-type="bibr" rid="ref69">2014</xref>; <xref ref-type="bibr" rid="ref20">Dhiman and Garg, 2014</xref>). Then, a higher level of parasites was found in the blood, skeletal muscles, and hearts of mice treated with a NADPH oxidase 2 (NOX2) inhibitor during the acute infection with clone Sylvio (DTU-I; <xref ref-type="bibr" rid="ref19">Dhiman and Garg, 2011</xref>). The opposite was observed in NOX2-deficient mice infected with either Y strain (DTU-II) or clone CL-Brener (DTU-VI), showing a decreased parasite burden in the peritoneal and splenic macrophages (<xref ref-type="bibr" rid="ref47">Paiva et al., 2012</xref>; <xref ref-type="bibr" rid="ref26">Goes et al., 2016</xref>). Further comparative studies are deserved considering that it is still unknown whether such differences are related to <italic>T. cruzi</italic> DTU type involved or, to the distinct functions of the ROS enzymes.</p>
<p>In conclusion, the self-sustaining ROS drives astrocyte infection by <italic>T. cruzi</italic>, and involve ROS production from HIV-exposed astrocytes during coinfection, contributing to parasite persistence and CNS pathology. Our original insights shed light on the pathogenesis of the neurologic Chagas disease, offering deeper information that supports the design of new parasite control strategies (<xref rid="fig5" ref-type="fig">Figure 5</xref>).</p>
<fig position="float" id="fig5">
<label>Figure 5</label>
<caption>
<p>The infection and multiplication of <italic>Trypanosoma cruzi</italic> in astrocytes is influenced by reactive oxygen species (ROS) generated during its infection or by prior HIV exposure.</p>
</caption>
<graphic xlink:href="fmicb-11-563320-g005.tif"/>
</fig>
</sec>
<sec id="sec17">
<title>Data Availability Statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="sec18">
<title>Author Contributions</title>
<p>JU, CC, and ME performed the experiments. All authors analyzed the data. JU, MD, and JQ wrote the article. MD and JQ designed the experiments, revised the article, and obtained research funding. All authors have read and approved the final manuscript.</p>
<sec id="sec19" sec-type="coi">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<ack>
<p>The authors thank Sergio Mazzini for his assistance and proofreading during the manuscript preparation.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="ref1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aguiar</surname> <given-names>P. H.</given-names></name> <name><surname>Furtado</surname> <given-names>C.</given-names></name> <name><surname>Repoles</surname> <given-names>B. M.</given-names></name> <name><surname>Ribeiro</surname> <given-names>G. A.</given-names></name> <name><surname>Mendes</surname> <given-names>I. C.</given-names></name> <name><surname>Peloso</surname> <given-names>E. F.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Oxidative stress and DNA lesions: the role of 8-oxoguanine lesions in <italic>Trypanosoma cruzi</italic> cell viability</article-title>. <source>PLoS Negl. Trop. Dis.</source> <volume>7</volume>:<fpage>e2279</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pntd.0002279</pub-id>, PMID: <pub-id pub-id-type="pmid">23785540</pub-id></citation></ref>
<ref id="ref2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname> <given-names>G. F.</given-names></name> <name><surname>Toth</surname> <given-names>R.</given-names></name> <name><surname>James</surname> <given-names>J.</given-names></name> <name><surname>Ganley</surname> <given-names>I. G.</given-names></name></person-group> (<year>2013</year>). <article-title>Loss of iron triggers PINK1/parkin-independent mitophagy</article-title>. <source>EMBO Rep.</source> <volume>14</volume>, <fpage>1127</fpage>&#x2013;<lpage>1135</lpage>. doi: <pub-id pub-id-type="doi">10.1038/embor.2013.168</pub-id>, PMID: <pub-id pub-id-type="pmid">24176932</pub-id></citation></ref>
<ref id="ref3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname> <given-names>H. H.</given-names></name> <name><surname>Johnsen</surname> <given-names>K. B.</given-names></name> <name><surname>Moos</surname> <given-names>T.</given-names></name></person-group> (<year>2014</year>). <article-title>Iron deposits in the chronically inflamed central nervous system and contributes to neurodegeneration</article-title>. <source>Cell. Mol. Life Sci.</source> <volume>71</volume>, <fpage>1607</fpage>&#x2013;<lpage>1622</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00018-013-1509-8</pub-id>, PMID: <pub-id pub-id-type="pmid">24218010</pub-id></citation></ref>
<ref id="ref4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arantes</surname> <given-names>J. M.</given-names></name> <name><surname>Pedrosa</surname> <given-names>M. L.</given-names></name> <name><surname>Martins</surname> <given-names>H. R.</given-names></name> <name><surname>Veloso</surname> <given-names>V. M.</given-names></name> <name><surname>de Lana</surname> <given-names>M.</given-names></name> <name><surname>Bahia</surname> <given-names>M. T.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title><italic>Trypanosoma cruzi</italic>: treatment with the iron chelator desferrioxamine reduces parasitemia and mortality in experimentally infected mice</article-title>. <source>Exp. Parasitol.</source> <volume>117</volume>, <fpage>43</fpage>&#x2013;<lpage>50</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.exppara.2007.03.006</pub-id>, PMID: <pub-id pub-id-type="pmid">17521632</pub-id></citation></ref>
<ref id="ref5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barat</surname> <given-names>C.</given-names></name> <name><surname>Proust</surname> <given-names>A.</given-names></name> <name><surname>Deshiere</surname> <given-names>A.</given-names></name> <name><surname>Leboeuf</surname> <given-names>M.</given-names></name> <name><surname>Drouin</surname> <given-names>J.</given-names></name> <name><surname>Tremblay</surname> <given-names>M. J.</given-names></name></person-group> (<year>2018</year>). <article-title>Astrocytes sustain long-term productive HIV-1 infection without establishment of reactivable viral latency</article-title>. <source>Glia</source> <volume>66</volume>, <fpage>1363</fpage>&#x2013;<lpage>1381</lpage>. doi: <pub-id pub-id-type="doi">10.1002/glia.23310</pub-id>, PMID: <pub-id pub-id-type="pmid">29464785</pub-id></citation></ref>
<ref id="ref6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bayer-Santos</surname> <given-names>E.</given-names></name> <name><surname>Aguilar-Bonavides</surname> <given-names>C.</given-names></name> <name><surname>Rodrigues</surname> <given-names>S. P.</given-names></name> <name><surname>Cordero</surname> <given-names>E. M.</given-names></name> <name><surname>Marques</surname> <given-names>A. F.</given-names></name> <name><surname>Varela-Ramirez</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Proteomic analysis of <italic>Trypanosoma cruzi</italic> secretome: characterization of two populations of extracellular vesicles and soluble proteins</article-title>. <source>J. Proteome Res.</source> <volume>12</volume>, <fpage>883</fpage>&#x2013;<lpage>897</lpage>. doi: <pub-id pub-id-type="doi">10.1021/pr300947g</pub-id>, PMID: <pub-id pub-id-type="pmid">23214914</pub-id></citation></ref>
<ref id="ref7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Benedikter</surname> <given-names>B. J.</given-names></name> <name><surname>Weseler</surname> <given-names>A. R.</given-names></name> <name><surname>Wouters</surname> <given-names>E. F. M.</given-names></name> <name><surname>Savelkoul</surname> <given-names>P. H. M.</given-names></name> <name><surname>Rohde</surname> <given-names>G. G. U.</given-names></name> <name><surname>Stassen</surname> <given-names>F. R. M.</given-names></name></person-group> (<year>2018</year>). <article-title>Redox-dependent thiol modifications: implications for the release of extracellular vesicles</article-title>. <source>Cell. Mol. Life Sci.</source> <volume>75</volume>, <fpage>2321</fpage>&#x2013;<lpage>2337</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00018-018-2806-z</pub-id>, PMID: <pub-id pub-id-type="pmid">29594387</pub-id></citation></ref>
<ref id="ref8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bern</surname> <given-names>C.</given-names></name> <name><surname>Kjos</surname> <given-names>S.</given-names></name> <name><surname>Yabsley</surname> <given-names>M. J.</given-names></name> <name><surname>Montgomery</surname> <given-names>S. P.</given-names></name></person-group> (<year>2011</year>). <article-title><italic>Trypanosoma cruzi</italic> and Chagas&#x2019; disease in the United States</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>24</volume>, <fpage>655</fpage>&#x2013;<lpage>681</lpage>. doi: <pub-id pub-id-type="doi">10.1128/CMR.00005-11</pub-id>, PMID: <pub-id pub-id-type="pmid">21976603</pub-id></citation></ref>
<ref id="ref9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blanchet</surname> <given-names>F. P.</given-names></name> <name><surname>Moris</surname> <given-names>A.</given-names></name> <name><surname>Nikolic</surname> <given-names>D. S.</given-names></name> <name><surname>Lehmann</surname> <given-names>M.</given-names></name> <name><surname>Cardinaud</surname> <given-names>S.</given-names></name> <name><surname>Stalder</surname> <given-names>R.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Human immunodeficiency virus-1 inhibition of immunoamphisomes in dendritic cells impairs early innate and adaptive immune responses</article-title>. <source>Immunity</source> <volume>32</volume>, <fpage>654</fpage>&#x2013;<lpage>669</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2010.04.011</pub-id>, PMID: <pub-id pub-id-type="pmid">20451412</pub-id></citation></ref>
<ref id="ref10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bodega</surname> <given-names>G.</given-names></name> <name><surname>Alique</surname> <given-names>M.</given-names></name> <name><surname>Puebla</surname> <given-names>L.</given-names></name> <name><surname>Carracedo</surname> <given-names>J.</given-names></name> <name><surname>Ramirez</surname> <given-names>R. M.</given-names></name></person-group> (<year>2019</year>). <article-title>Microvesicles: ROS scavengers and ROS producers</article-title>. <source>J. Extracell Vesicles</source> <volume>8</volume>:<fpage>1626654</fpage>. doi: <pub-id pub-id-type="doi">10.1080/20013078.2019.1626654</pub-id>, PMID: <pub-id pub-id-type="pmid">31258880</pub-id></citation></ref>
<ref id="ref11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Caeiro</surname> <given-names>L. D.</given-names></name> <name><surname>Alba-Soto</surname> <given-names>C. D.</given-names></name> <name><surname>Rizzi</surname> <given-names>M.</given-names></name> <name><surname>Solana</surname> <given-names>M. E.</given-names></name> <name><surname>Rodriguez</surname> <given-names>G.</given-names></name> <name><surname>Chidichimo</surname> <given-names>A. M.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>The protein family TcTASV-C is a novel <italic>Trypanosoma cruzi</italic> virulence factor secreted in extracellular vesicles by trypomastigotes and highly expressed in bloodstream forms</article-title>. <source>PLoS Negl. Trop. Dis.</source> <volume>12</volume>:<fpage>e0006475</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pntd.0006475</pub-id>, PMID: <pub-id pub-id-type="pmid">29727453</pub-id></citation></ref>
<ref id="ref12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Caradonna</surname> <given-names>K. L.</given-names></name> <name><surname>Engel</surname> <given-names>J. C.</given-names></name> <name><surname>Jacobi</surname> <given-names>D.</given-names></name> <name><surname>Lee</surname> <given-names>C. H.</given-names></name> <name><surname>Burleigh</surname> <given-names>B. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Host metabolism regulates intracellular growth of <italic>Trypanosoma cruzi</italic></article-title>. <source>Cell Host Microbe</source> <volume>13</volume>, <fpage>108</fpage>&#x2013;<lpage>117</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.chom.2012.11.011</pub-id>, PMID: <pub-id pub-id-type="pmid">23332160</pub-id></citation></ref>
<ref id="ref13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cestari</surname> <given-names>I.</given-names></name> <name><surname>Ansa-Addo</surname> <given-names>E.</given-names></name> <name><surname>Deolindo</surname> <given-names>P.</given-names></name> <name><surname>Inal</surname> <given-names>J. M.</given-names></name> <name><surname>Ramirez</surname> <given-names>M. I.</given-names></name></person-group> (<year>2012</year>). <article-title><italic>Trypanosoma cruzi</italic> immune evasion mediated by host cell-derived microvesicles</article-title>. <source>J. Immunol.</source> <volume>188</volume>, <fpage>1942</fpage>&#x2013;<lpage>1952</lpage>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1102053</pub-id>, PMID: <pub-id pub-id-type="pmid">22262654</pub-id></citation></ref>
<ref id="ref14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chassagne</surname> <given-names>J.</given-names></name> <name><surname>Verrelle</surname> <given-names>P.</given-names></name> <name><surname>Dionet</surname> <given-names>C.</given-names></name> <name><surname>Clavel</surname> <given-names>F.</given-names></name> <name><surname>Barre-Sinoussi</surname> <given-names>F.</given-names></name> <name><surname>Chermann</surname> <given-names>J. C.</given-names></name> <etal/></person-group>. (<year>1986</year>). <article-title>A monoclonal antibody against LAV gag precursor: use for viral protein analysis and antigenic expression in infected cells</article-title>. <source>J. Immunol.</source> <volume>136</volume>, <fpage>1442</fpage>&#x2013;<lpage>1445</lpage>. PMID: <pub-id pub-id-type="pmid">3003197</pub-id></citation></ref>
<ref id="ref15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>K.</given-names></name> <name><surname>Phan</surname> <given-names>T.</given-names></name> <name><surname>Lin</surname> <given-names>A.</given-names></name> <name><surname>Sardo</surname> <given-names>L.</given-names></name> <name><surname>Mele</surname> <given-names>A. R.</given-names></name> <name><surname>Nonnemacher</surname> <given-names>M. R.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Morphine exposure exacerbates HIV-1 Tat driven changes to neuroinflammatory factors in cultured astrocytes</article-title>. <source>PLoS One</source> <volume>15</volume>:<fpage>e0230563</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0230563</pub-id>, PMID: <pub-id pub-id-type="pmid">32210470</pub-id></citation></ref>
<ref id="ref16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cordova</surname> <given-names>E.</given-names></name> <name><surname>Boschi</surname> <given-names>A.</given-names></name> <name><surname>Ambrosioni</surname> <given-names>J.</given-names></name> <name><surname>Cudos</surname> <given-names>C.</given-names></name> <name><surname>Corti</surname> <given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>Reactivation of Chagas disease with central nervous system involvement in HIV-infected patients in Argentina, 1992-2007</article-title>. <source>Int. J. Infect. Dis.</source> <volume>12</volume>, <fpage>587</fpage>&#x2013;<lpage>592</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ijid.2007.12.007</pub-id>, PMID: <pub-id pub-id-type="pmid">18337139</pub-id></citation></ref>
<ref id="ref17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Darden</surname> <given-names>J. M.</given-names></name> <name><surname>Polonis</surname> <given-names>V. R.</given-names></name> <name><surname>Desouza</surname> <given-names>M. S.</given-names></name> <name><surname>Chantakulkij</surname> <given-names>S.</given-names></name> <name><surname>Brown</surname> <given-names>A. E.</given-names></name> <name><surname>Birx</surname> <given-names>D. L.</given-names></name> <etal/></person-group>. (<year>2000</year>). <article-title>A flow cytometric method for measuring neutralization of HIV-1 subtype B and E primary isolates</article-title>. <source>Cytometry</source> <volume>40</volume>, <fpage>141</fpage>&#x2013;<lpage>150</lpage>. doi: <pub-id pub-id-type="doi">10.1002/(SICI)1097-0320(20000601)40:2&#x003C;141::AID-CYTO8&#x003E;3.0.CO;2-F</pub-id>, PMID: <pub-id pub-id-type="pmid">10805934</pub-id></citation></ref>
<ref id="ref18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Souza</surname> <given-names>W.</given-names></name> <name><surname>De Carvalho</surname> <given-names>T. M.</given-names></name> <name><surname>Barrias</surname> <given-names>E. S.</given-names></name></person-group> (<year>2010</year>). <article-title>Review on <italic>Trypanosoma cruzi</italic>: host cell interaction</article-title>. <source>Int. J. Cell Biol.</source> <volume>2010</volume>:<fpage>295394</fpage>. doi: <pub-id pub-id-type="doi">10.1155/2010/295394</pub-id>, PMID: <pub-id pub-id-type="pmid">20811486</pub-id></citation></ref>
<ref id="ref19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dhiman</surname> <given-names>M.</given-names></name> <name><surname>Garg</surname> <given-names>N. J.</given-names></name></person-group> (<year>2011</year>). <article-title>NADPH oxidase inhibition ameliorates <italic>Trypanosoma cruzi</italic>-induced myocarditis during Chagas disease</article-title>. <source>J. Pathol.</source> <volume>225</volume>, <fpage>583</fpage>&#x2013;<lpage>596</lpage>. doi: <pub-id pub-id-type="doi">10.1002/path.2975</pub-id>, PMID: <pub-id pub-id-type="pmid">21952987</pub-id></citation></ref>
<ref id="ref20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dhiman</surname> <given-names>M.</given-names></name> <name><surname>Garg</surname> <given-names>N. J.</given-names></name></person-group> (<year>2014</year>). <article-title>P47phox&#x2212;/&#x2212; mice are compromised in expansion and activation of CD8&#x002B; T cells and susceptible to <italic>Trypanosoma cruzi</italic> infection</article-title>. <source>PLoS Pathog.</source> <volume>10</volume>:<fpage>e1004516</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1004516</pub-id>, PMID: <pub-id pub-id-type="pmid">25474113</pub-id></citation></ref>
<ref id="ref21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dias</surname> <given-names>P. P.</given-names></name> <name><surname>Capila</surname> <given-names>R. F.</given-names></name> <name><surname>Do Couto</surname> <given-names>N. F.</given-names></name> <name><surname>Estrada</surname> <given-names>D.</given-names></name> <name><surname>Gadelha</surname> <given-names>F. R.</given-names></name> <name><surname>Radi</surname> <given-names>R.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Cardiomyocyte oxidants production may signal to <italic>T. cruzi</italic> intracellular development</article-title>. <source>PLoS Negl. Trop. Dis.</source> <volume>11</volume>:<fpage>e0005852</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pntd.0005852</pub-id>, PMID: <pub-id pub-id-type="pmid">28832582</pub-id></citation></ref>
<ref id="ref22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dick</surname> <given-names>C. F.</given-names></name> <name><surname>de Moura Guimaraes</surname> <given-names>L.</given-names></name> <name><surname>Carvalho-Kelly</surname> <given-names>L. F.</given-names></name> <name><surname>Cortes</surname> <given-names>A. L.</given-names></name> <name><surname>da Silva Lara Morcillo</surname> <given-names>L.</given-names></name> <name><surname>da Silva Sampaio</surname> <given-names>L.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>A ferric reductase of <italic>Trypanosoma cruzi</italic> (TcFR) is involved in iron metabolism in the parasite</article-title>. <source>Exp. Parasitol.</source> <volume>217</volume>:<fpage>107962</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.exppara.2020.107962</pub-id>, PMID: <pub-id pub-id-type="pmid">32763249</pub-id></citation></ref>
<ref id="ref23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ellis</surname> <given-names>R. J.</given-names></name> <name><surname>Calero</surname> <given-names>P.</given-names></name> <name><surname>Stockin</surname> <given-names>M. D.</given-names></name></person-group> (<year>2009</year>). <article-title>HIV infection and the central nervous system: a primer</article-title>. <source>Neuropsychol. Rev.</source> <volume>19</volume>, <fpage>144</fpage>&#x2013;<lpage>151</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11065-009-9094-1</pub-id>, PMID: <pub-id pub-id-type="pmid">19415500</pub-id></citation></ref>
<ref id="ref24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eugenin</surname> <given-names>E. A.</given-names></name> <name><surname>Basilio</surname> <given-names>D.</given-names></name> <name><surname>Saez</surname> <given-names>J. C.</given-names></name> <name><surname>Orellana</surname> <given-names>J. A.</given-names></name> <name><surname>Raine</surname> <given-names>C. S.</given-names></name> <name><surname>Bukauskas</surname> <given-names>F.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>The role of gap junction channels during physiologic and pathologic conditions of the human central nervous system</article-title>. <source>J. Neuroimmune Pharmacol.</source> <volume>7</volume>, <fpage>499</fpage>&#x2013;<lpage>518</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11481-012-9352-5</pub-id>, PMID: <pub-id pub-id-type="pmid">22438035</pub-id></citation></ref>
<ref id="ref25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferreira</surname> <given-names>M. S.</given-names></name> <name><surname>Nishioka Sde</surname> <given-names>A.</given-names></name> <name><surname>Silvestre</surname> <given-names>M. T.</given-names></name> <name><surname>Borges</surname> <given-names>A. S.</given-names></name> <name><surname>Nunes-Araujo</surname> <given-names>F. R.</given-names></name> <name><surname>Rocha</surname> <given-names>A.</given-names></name></person-group> (<year>1997</year>). <article-title>Reactivation of Chagas&#x2019; disease in patients with AIDS: report of three new cases and review of the literature</article-title>. <source>Clin. Infect. Dis.</source> <volume>25</volume>, <fpage>1397</fpage>&#x2013;<lpage>1400</lpage>. doi: <pub-id pub-id-type="doi">10.1086/516130</pub-id>, PMID: <pub-id pub-id-type="pmid">9431385</pub-id></citation></ref>
<ref id="ref26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goes</surname> <given-names>G. R.</given-names></name> <name><surname>Rocha</surname> <given-names>P. S.</given-names></name> <name><surname>Diniz</surname> <given-names>A. R.</given-names></name> <name><surname>Aguiar</surname> <given-names>P. H.</given-names></name> <name><surname>Machado</surname> <given-names>C. R.</given-names></name> <name><surname>Vieira</surname> <given-names>L. Q.</given-names></name></person-group> (<year>2016</year>). <article-title><italic>Trypanosoma cruzi</italic> needs a signal provided by reactive oxygen species to infect macrophages</article-title>. <source>PLoS Negl. Trop. Dis.</source> <volume>10</volume>:<fpage>e0004555</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pntd.0004555</pub-id>, PMID: <pub-id pub-id-type="pmid">27035573</pub-id></citation></ref>
<ref id="ref27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gomez</surname> <given-names>C. A.</given-names></name> <name><surname>Banaei</surname> <given-names>N.</given-names></name></person-group> (<year>2018</year>). <article-title><italic>Trypanosoma cruzi</italic> reactivation in the brain</article-title>. <source>N. Engl. J. Med.</source> <volume>378</volume>:<fpage>1824</fpage>. doi: <pub-id pub-id-type="doi">10.1056/NEJMicm1703763</pub-id>, PMID: <pub-id pub-id-type="pmid">29742366</pub-id></citation></ref>
<ref id="ref28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goncalves</surname> <given-names>M. F.</given-names></name> <name><surname>Umezawa</surname> <given-names>E. S.</given-names></name> <name><surname>Katzin</surname> <given-names>A. M.</given-names></name> <name><surname>de Souza</surname> <given-names>W.</given-names></name> <name><surname>Alves</surname> <given-names>M. J.</given-names></name> <name><surname>Zingales</surname> <given-names>B.</given-names></name> <etal/></person-group>. (<year>1991</year>). <article-title><italic>Trypanosoma cruzi</italic>: shedding of surface antigens as membrane vesicles</article-title>. <source>Exp. Parasitol.</source> <volume>72</volume>, <fpage>43</fpage>&#x2013;<lpage>53</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0014-4894(91)90119-h</pub-id>, PMID: <pub-id pub-id-type="pmid">1993464</pub-id></citation></ref>
<ref id="ref29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guinazu</surname> <given-names>N.</given-names></name> <name><surname>Carrera-Silva</surname> <given-names>E. A.</given-names></name> <name><surname>Becerra</surname> <given-names>M. C.</given-names></name> <name><surname>Pellegrini</surname> <given-names>A.</given-names></name> <name><surname>Albesa</surname> <given-names>I.</given-names></name> <name><surname>Gea</surname> <given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>Induction of NADPH oxidase activity and reactive oxygen species production by a single <italic>Trypanosoma cruzi</italic> antigen</article-title>. <source>Int. J. Parasitol.</source> <volume>40</volume>, <fpage>1531</fpage>&#x2013;<lpage>1538</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ijpara.2010.05.012</pub-id>, PMID: <pub-id pub-id-type="pmid">20637209</pub-id></citation></ref>
<ref id="ref30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname> <given-names>S.</given-names></name> <name><surname>Bhatia</surname> <given-names>V.</given-names></name> <name><surname>Wen</surname> <given-names>J. J.</given-names></name> <name><surname>Wu</surname> <given-names>Y.</given-names></name> <name><surname>Huang</surname> <given-names>M. H.</given-names></name> <name><surname>Garg</surname> <given-names>N. J.</given-names></name></person-group> (<year>2009</year>). <article-title><italic>Trypanosoma cruzi</italic> infection disturbs mitochondrial membrane potential and ROS production rate in cardiomyocytes</article-title>. <source>Free Radic. Biol. Med.</source> <volume>47</volume>, <fpage>1414</fpage>&#x2013;<lpage>1421</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2009.08.008</pub-id>, PMID: <pub-id pub-id-type="pmid">19686837</pub-id></citation></ref>
<ref id="ref31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname> <given-names>S.</given-names></name> <name><surname>Cordeiro</surname> <given-names>A. T.</given-names></name> <name><surname>Michels</surname> <given-names>P. A.</given-names></name></person-group> (<year>2011</year>). <article-title>Glucose-6-phosphate dehydrogenase is the target for the trypanocidal action of human steroids</article-title>. <source>Mol. Biochem. Parasitol.</source> <volume>176</volume>, <fpage>112</fpage>&#x2013;<lpage>115</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.molbiopara.2010.12.006</pub-id>, PMID: <pub-id pub-id-type="pmid">21185333</pub-id></citation></ref>
<ref id="ref32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>B. K.</given-names></name> <name><surname>Sikes</surname> <given-names>H. D.</given-names></name></person-group> (<year>2014</year>). <article-title>Quantifying intracellular hydrogen peroxide perturbations in terms of concentration</article-title>. <source>Redox Biol.</source> <volume>2</volume>, <fpage>955</fpage>&#x2013;<lpage>962</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.redox.2014.08.001</pub-id>, PMID: <pub-id pub-id-type="pmid">25460730</pub-id></citation></ref>
<ref id="ref33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hugo</surname> <given-names>M.</given-names></name> <name><surname>Martinez</surname> <given-names>A.</given-names></name> <name><surname>Trujillo</surname> <given-names>M.</given-names></name> <name><surname>Estrada</surname> <given-names>D.</given-names></name> <name><surname>Mastrogiovanni</surname> <given-names>M.</given-names></name> <name><surname>Linares</surname> <given-names>E.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Kinetics, subcellular localization, and contribution to parasite virulence of a <italic>Trypanosoma cruzi</italic> hybrid type a heme peroxidase (TcAPx-CcP)</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>114</volume>, <fpage>E1326</fpage>&#x2013;<lpage>E1335</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.1618611114</pub-id>, PMID: <pub-id pub-id-type="pmid">28179568</pub-id></citation></ref>
<ref id="ref34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jansen</surname> <given-names>A. M.</given-names></name> <name><surname>Xavier</surname> <given-names>S.</given-names></name> <name><surname>Roque</surname> <given-names>A. L. R.</given-names></name></person-group> (<year>2020</year>). <article-title>Landmarks of the knowledge and <italic>Trypanosoma cruzi</italic> biology in the wild environment</article-title>. <source>Front. Cell. Infect. Microbiol.</source> <volume>10</volume>:<fpage>10</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fcimb.2020.00010</pub-id>, PMID: <pub-id pub-id-type="pmid">32117794</pub-id></citation></ref>
<ref id="ref35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jou</surname> <given-names>M. J.</given-names></name></person-group> (<year>2008</year>). <article-title>Pathophysiological and pharmacological implications of mitochondria-targeted reactive oxygen species generation in astrocytes</article-title>. <source>Adv. Drug Deliv. Rev.</source> <volume>60</volume>, <fpage>1512</fpage>&#x2013;<lpage>1526</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.addr.2008.06.004</pub-id>, PMID: <pub-id pub-id-type="pmid">18692534</pub-id></citation></ref>
<ref id="ref36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kiray</surname> <given-names>H.</given-names></name> <name><surname>Lindsay</surname> <given-names>S. L.</given-names></name> <name><surname>Hosseinzadeh</surname> <given-names>S.</given-names></name> <name><surname>Barnett</surname> <given-names>S. C.</given-names></name></person-group> (<year>2016</year>). <article-title>The multifaceted role of astrocytes in regulating myelination</article-title>. <source>Exp. Neurol.</source> <volume>283</volume>, <fpage>541</fpage>&#x2013;<lpage>549</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.expneurol.2016.03.009</pub-id>, PMID: <pub-id pub-id-type="pmid">26988764</pub-id></citation></ref>
<ref id="ref37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koo</surname> <given-names>S. J.</given-names></name> <name><surname>Szczesny</surname> <given-names>B.</given-names></name> <name><surname>Wan</surname> <given-names>X.</given-names></name> <name><surname>Putluri</surname> <given-names>N.</given-names></name> <name><surname>Garg</surname> <given-names>N. J.</given-names></name></person-group> (<year>2018</year>). <article-title>Pentose phosphate shunt modulates reactive oxygen species and nitric oxide production controlling <italic>Trypanosoma cruzi</italic> in macrophages</article-title>. <source>Front. Immunol.</source> <volume>9</volume>:<fpage>202</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2018.00202</pub-id>, PMID: <pub-id pub-id-type="pmid">29503646</pub-id></citation></ref>
<ref id="ref38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lattes</surname> <given-names>R.</given-names></name> <name><surname>Lasala</surname> <given-names>M. B.</given-names></name></person-group> (<year>2014</year>). <article-title>Chagas disease in the immunosuppressed patient</article-title>. <source>Clin. Microbiol. Infect.</source> <volume>20</volume>, <fpage>300</fpage>&#x2013;<lpage>309</lpage>. doi: <pub-id pub-id-type="doi">10.1111/1469-0691.12585</pub-id>, PMID: <pub-id pub-id-type="pmid">24602129</pub-id></citation></ref>
<ref id="ref39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>G. H.</given-names></name> <name><surname>Maric</surname> <given-names>D.</given-names></name> <name><surname>Major</surname> <given-names>E. O.</given-names></name> <name><surname>Nath</surname> <given-names>A.</given-names></name></person-group> (<year>2020</year>). <article-title>Productive HIV infection in astrocytes can be established via a non-classical mechanism</article-title>. <source>AIDS</source>. doi: <pub-id pub-id-type="doi">10.1097/QAD.0000000000002512</pub-id>, PMID: <pub-id pub-id-type="pmid">32073447</pub-id> <comment>[Epub ahead of print]</comment></citation></ref>
<ref id="ref40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lovo-Martins</surname> <given-names>M. I.</given-names></name> <name><surname>Malvezi</surname> <given-names>A. D.</given-names></name> <name><surname>Zanluqui</surname> <given-names>N. G.</given-names></name> <name><surname>Lucchetti</surname> <given-names>B. F. C.</given-names></name> <name><surname>Tatakihara</surname> <given-names>V. L. H.</given-names></name> <name><surname>Morking</surname> <given-names>P. A.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Extracellular vesicles shed by <italic>Trypanosoma cruzi</italic> potentiate infection and elicit lipid body formation and PGE2 production in murine macrophages</article-title>. <source>Front. Immunol.</source> <volume>9</volume>:<fpage>896</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2018.00896</pub-id>, PMID: <pub-id pub-id-type="pmid">29755471</pub-id></citation></ref>
<ref id="ref41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Manque</surname> <given-names>P. A.</given-names></name> <name><surname>Probst</surname> <given-names>C. M.</given-names></name> <name><surname>Pereira</surname> <given-names>M. C.</given-names></name> <name><surname>Rampazzo</surname> <given-names>R. C.</given-names></name> <name><surname>Ozaki</surname> <given-names>L. S.</given-names></name> <name><surname>Pavoni</surname> <given-names>D. P.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title><italic>Trypanosoma cruzi</italic> infection induces a global host cell response in cardiomyocytes</article-title>. <source>Infect. Immun.</source> <volume>79</volume>, <fpage>1855</fpage>&#x2013;<lpage>1862</lpage>. doi: <pub-id pub-id-type="doi">10.1128/IAI.00643-10</pub-id>, PMID: <pub-id pub-id-type="pmid">21343357</pub-id></citation></ref>
<ref id="ref42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mehta</surname> <given-names>S. R.</given-names></name> <name><surname>Perez-Santiago</surname> <given-names>J.</given-names></name> <name><surname>Hulgan</surname> <given-names>T.</given-names></name> <name><surname>Day</surname> <given-names>T. R.</given-names></name> <name><surname>Barnholtz-Sloan</surname> <given-names>J.</given-names></name> <name><surname>Gittleman</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment</article-title>. <source>J. Neuroinflammation</source> <volume>14</volume>:<fpage>72</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12974-017-0848-z</pub-id>, PMID: <pub-id pub-id-type="pmid">28359324</pub-id></citation></ref>
<ref id="ref43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mesias</surname> <given-names>A. C.</given-names></name> <name><surname>Garg</surname> <given-names>N. J.</given-names></name> <name><surname>Zago</surname> <given-names>M. P.</given-names></name></person-group> (<year>2019</year>). <article-title>Redox balance keepers and possible cell functions managed by redox homeostasis in <italic>Trypanosoma cruzi</italic></article-title>. <source>Front. Cell. Infect. Microbiol.</source> <volume>9</volume>:<fpage>435</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fcimb.2019.00435</pub-id>, PMID: <pub-id pub-id-type="pmid">31921709</pub-id></citation></ref>
<ref id="ref44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nathan</surname> <given-names>C.</given-names></name> <name><surname>Nogueira</surname> <given-names>N.</given-names></name> <name><surname>Juangbhanich</surname> <given-names>C.</given-names></name> <name><surname>Ellis</surname> <given-names>J.</given-names></name> <name><surname>Cohn</surname> <given-names>Z.</given-names></name></person-group> (<year>1979</year>). <article-title>Activation of macrophages in vivo and in vitro, Correlation between hydrogen peroxide release and killing of <italic>Trypanosoma cruzi</italic></article-title>. <source>J. Exp. Med.</source> <volume>149</volume><fpage>1056</fpage>&#x2013;<lpage>1068</lpage>. doi: <pub-id pub-id-type="doi">10.1084/jem.149.5.1056</pub-id>, PMID: <pub-id pub-id-type="pmid">376774</pub-id></citation></ref>
<ref id="ref45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ojeda</surname> <given-names>D. S.</given-names></name> <name><surname>Grasso</surname> <given-names>D.</given-names></name> <name><surname>Urquiza</surname> <given-names>J.</given-names></name> <name><surname>Till</surname> <given-names>A.</given-names></name> <name><surname>Vaccaro</surname> <given-names>M. I.</given-names></name> <name><surname>Quarleri</surname> <given-names>J.</given-names></name></person-group> (<year>2018</year>). <article-title>Cell death is counteracted by Mitophagy in HIV-productively infected astrocytes but is promoted by Inflammasome activation among non-productively infected cells</article-title>. <source>Front. Immunol.</source> <volume>9</volume>:<fpage>2633</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2018.02633</pub-id>, PMID: <pub-id pub-id-type="pmid">30515154</pub-id></citation></ref>
<ref id="ref46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pacheco</surname> <given-names>A. L.</given-names></name> <name><surname>Vicentini</surname> <given-names>G.</given-names></name> <name><surname>Matteucci</surname> <given-names>K. C.</given-names></name> <name><surname>Ribeiro</surname> <given-names>R. R.</given-names></name> <name><surname>Weinlich</surname> <given-names>R.</given-names></name> <name><surname>Bortoluci</surname> <given-names>K. R.</given-names></name></person-group> (<year>2019</year>). <article-title>The impairment in the NLRP3-induced NO secretion renders astrocytes highly permissive to <italic>T. cruzi</italic> replication</article-title>. <source>J. Leukoc. Biol.</source> <volume>106</volume>, <fpage>201</fpage>&#x2013;<lpage>207</lpage>. doi: <pub-id pub-id-type="doi">10.1002/JLB.4AB1118-416RR</pub-id>, PMID: <pub-id pub-id-type="pmid">30997938</pub-id></citation></ref>
<ref id="ref47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Paiva</surname> <given-names>C. N.</given-names></name> <name><surname>Feijo</surname> <given-names>D. F.</given-names></name> <name><surname>Dutra</surname> <given-names>F. F.</given-names></name> <name><surname>Carneiro</surname> <given-names>V. C.</given-names></name> <name><surname>Freitas</surname> <given-names>G. B.</given-names></name> <name><surname>Alves</surname> <given-names>L. S.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Oxidative stress fuels <italic>Trypanosoma cruzi</italic> infection in mice</article-title>. <source>J. Clin. Invest.</source> <volume>122</volume>, <fpage>2531</fpage>&#x2013;<lpage>2542</lpage>. doi: <pub-id pub-id-type="doi">10.1172/JCI58525</pub-id>, PMID: <pub-id pub-id-type="pmid">22728935</pub-id></citation></ref>
<ref id="ref48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Paiva</surname> <given-names>C. N.</given-names></name> <name><surname>Medei</surname> <given-names>E.</given-names></name> <name><surname>Bozza</surname> <given-names>M. T.</given-names></name></person-group> (<year>2018</year>). <article-title>ROS and <italic>Trypanosoma cruzi</italic>: fuel to infection, poison to the heart</article-title>. <source>PLoS Pathog.</source> <volume>14</volume>:<fpage>e1006928</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1006928</pub-id>, PMID: <pub-id pub-id-type="pmid">29672619</pub-id></citation></ref>
<ref id="ref49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perez-Molina</surname> <given-names>J. A.</given-names></name> <name><surname>Molina</surname> <given-names>I.</given-names></name></person-group> (<year>2018</year>). <article-title>Chagas disease</article-title>. <source>Lancet</source> <volume>391</volume>, <fpage>82</fpage>&#x2013;<lpage>94</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(17)31612-4</pub-id>, PMID: <pub-id pub-id-type="pmid">28673423</pub-id></citation></ref>
<ref id="ref50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Proust</surname> <given-names>A.</given-names></name> <name><surname>Barat</surname> <given-names>C.</given-names></name> <name><surname>Leboeuf</surname> <given-names>M.</given-names></name> <name><surname>Drouin</surname> <given-names>J.</given-names></name> <name><surname>Gagnon</surname> <given-names>M. T.</given-names></name> <name><surname>Vanasse</surname> <given-names>F.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>HIV-1 infection and latency-reversing agents bryostatin-1 and JQ1 disrupt amyloid beta homeostasis in human astrocytes</article-title>. <source>Glia</source> <volume>68</volume>, <fpage>2212</fpage>&#x2013;<lpage>2227</lpage>. doi: <pub-id pub-id-type="doi">10.1002/glia.23833</pub-id>, PMID: <pub-id pub-id-type="pmid">32250524</pub-id></citation></ref>
<ref id="ref51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Providello</surname> <given-names>M. V.</given-names></name> <name><surname>Carneiro</surname> <given-names>Z. A.</given-names></name> <name><surname>Portapilla</surname> <given-names>G. B.</given-names></name> <name><surname>do Vale</surname> <given-names>G. T.</given-names></name> <name><surname>Camargo</surname> <given-names>R. S.</given-names></name> <name><surname>Tirapelli</surname> <given-names>C. R.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Benefits of ascorbic acid in association with low-dose benznidazole in treatment of Chagas disease</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>62</volume>, <fpage>e00514</fpage>&#x2013;<lpage>e00518</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.00514-18</pub-id>, PMID: <pub-id pub-id-type="pmid">29987143</pub-id></citation></ref>
<ref id="ref52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ramirez</surname> <given-names>M. I.</given-names></name> <name><surname>Deolindo</surname> <given-names>P.</given-names></name> <name><surname>de Messias-Reason</surname> <given-names>I. J.</given-names></name> <name><surname>Arigi</surname> <given-names>E. A.</given-names></name> <name><surname>Choi</surname> <given-names>H.</given-names></name> <name><surname>Almeida</surname> <given-names>I. C.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Dynamic flux of microvesicles modulate parasite-host cell interaction of <italic>Trypanosoma cruzi</italic> in eukaryotic cells</article-title>. <source>Cell. Microbiol.</source> <volume>19</volume>, <fpage>1</fpage>&#x2013;<lpage>15</lpage>. doi: <pub-id pub-id-type="doi">10.1111/cmi.12672</pub-id>, PMID: <pub-id pub-id-type="pmid">27665486</pub-id></citation></ref>
<ref id="ref53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Retana Moreira</surname> <given-names>L.</given-names></name> <name><surname>Rodriguez Serrano</surname> <given-names>F.</given-names></name> <name><surname>Osuna</surname> <given-names>A.</given-names></name></person-group> (<year>2019</year>). <article-title>Extracellular vesicles of <italic>Trypanosoma cruzi</italic> tissue-culture cell-derived trypomastigotes: induction of physiological changes in non-parasitized culture cells</article-title>. <source>PLoS Negl. Trop. Dis.</source> <volume>13</volume>:<fpage>e0007163</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pntd.0007163</pub-id>, PMID: <pub-id pub-id-type="pmid">30789912</pub-id></citation></ref>
<ref id="ref54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schijman</surname> <given-names>A. G.</given-names></name> <name><surname>Bisio</surname> <given-names>M.</given-names></name> <name><surname>Orellana</surname> <given-names>L.</given-names></name> <name><surname>Sued</surname> <given-names>M.</given-names></name> <name><surname>Duffy</surname> <given-names>T.</given-names></name> <name><surname>Mejia Jaramillo</surname> <given-names>A. M.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>International study to evaluate PCR methods for detection of <italic>Trypanosoma cruzi</italic> DNA in blood samples from Chagas disease patients</article-title>. <source>PLoS Negl. Trop. Dis.</source> <volume>5</volume>:<fpage>e931</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pntd.0000931</pub-id>, PMID: <pub-id pub-id-type="pmid">21264349</pub-id></citation></ref>
<ref id="ref55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname> <given-names>V.</given-names></name> <name><surname>Mishra</surname> <given-names>M.</given-names></name> <name><surname>Ghosh</surname> <given-names>S.</given-names></name> <name><surname>Tewari</surname> <given-names>R.</given-names></name> <name><surname>Basu</surname> <given-names>A.</given-names></name> <name><surname>Seth</surname> <given-names>P.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>Modulation of interleukin-1beta mediated inflammatory response in human astrocytes by flavonoids: implications in neuroprotection</article-title>. <source>Brain Res. Bull.</source> <volume>73</volume>, <fpage>55</fpage>&#x2013;<lpage>63</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.brainresbull.2007.01.016</pub-id>, PMID: <pub-id pub-id-type="pmid">17499637</pub-id></citation></ref>
<ref id="ref56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sheng</surname> <given-names>W. S.</given-names></name> <name><surname>Hu</surname> <given-names>S.</given-names></name> <name><surname>Feng</surname> <given-names>A.</given-names></name> <name><surname>Rock</surname> <given-names>R. B.</given-names></name></person-group> (<year>2013</year>). <article-title>Reactive oxygen species from human astrocytes induced functional impairment and oxidative damage</article-title>. <source>Neurochem. Res.</source> <volume>38</volume>, <fpage>2148</fpage>&#x2013;<lpage>2159</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11064-013-1123-z</pub-id>, PMID: <pub-id pub-id-type="pmid">23918204</pub-id></citation></ref>
<ref id="ref58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname> <given-names>R. R.</given-names></name> <name><surname>Mariante</surname> <given-names>R. M.</given-names></name> <name><surname>Silva</surname> <given-names>A. A.</given-names></name> <name><surname>Dos Santos</surname> <given-names>A. L.</given-names></name> <name><surname>Roffe</surname> <given-names>E.</given-names></name> <name><surname>Santiago</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Interferon-gamma promotes infection of astrocytes by <italic>Trypanosoma cruzi</italic></article-title>. <source>PLoS One</source> <volume>10</volume>:<fpage>e0118600</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0118600</pub-id>, PMID: <pub-id pub-id-type="pmid">25695249</pub-id></citation></ref>
<ref id="ref57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname> <given-names>A. A.</given-names></name> <name><surname>Silva</surname> <given-names>R. R.</given-names></name> <name><surname>Gibaldi</surname> <given-names>D.</given-names></name> <name><surname>Mariante</surname> <given-names>R. M.</given-names></name> <name><surname>Dos Santos</surname> <given-names>J. B.</given-names></name> <name><surname>Pereira</surname> <given-names>I. R.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Priming astrocytes with TNF enhances their susceptibility to <italic>Trypanosoma cruzi</italic> infection and creates a self-sustaining inflammatory milieu</article-title>. <source>J. Neuroinflammation</source> <volume>14</volume>:<fpage>182</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12974-017-0952-0</pub-id>, PMID: <pub-id pub-id-type="pmid">28877735</pub-id></citation></ref>
<ref id="ref59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sofroniew</surname> <given-names>M. V.</given-names></name> <name><surname>Vinters</surname> <given-names>H. V.</given-names></name></person-group> (<year>2010</year>). <article-title>Astrocytes: biology and pathology</article-title>. <source>Acta Neuropathol.</source> <volume>119</volume>, <fpage>7</fpage>&#x2013;<lpage>35</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00401-009-0619-8</pub-id>, PMID: <pub-id pub-id-type="pmid">20012068</pub-id></citation></ref>
<ref id="ref60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Song</surname> <given-names>H. Y.</given-names></name> <name><surname>Ryu</surname> <given-names>J.</given-names></name> <name><surname>Ju</surname> <given-names>S. M.</given-names></name> <name><surname>Park</surname> <given-names>L. J.</given-names></name> <name><surname>Lee</surname> <given-names>J. A.</given-names></name> <name><surname>Choi</surname> <given-names>S. Y.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>Extracellular HIV-1 Tat enhances monocyte adhesion by up-regulation of ICAM-1 and VCAM-1 gene expression via ROS-dependent NF-kappaB activation in astrocytes</article-title>. <source>Exp. Mol. Med.</source> <volume>39</volume>, <fpage>27</fpage>&#x2013;<lpage>37</lpage>. doi: <pub-id pub-id-type="doi">10.1038/emm.2007.4</pub-id>, PMID: <pub-id pub-id-type="pmid">17334226</pub-id></citation></ref>
<ref id="ref61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stempin</surname> <given-names>C. C.</given-names></name> <name><surname>Garrido</surname> <given-names>V. V.</given-names></name> <name><surname>Dulgerian</surname> <given-names>L. R.</given-names></name> <name><surname>Cerban</surname> <given-names>F. M.</given-names></name></person-group> (<year>2008</year>). <article-title>Cruzipain and SP600125 induce p38 activation, alter NO/arginase balance and favor the survival of <italic>Trypanosoma cruzi</italic> in macrophages</article-title>. <source>Acta Trop.</source> <volume>106</volume>, <fpage>119</fpage>&#x2013;<lpage>127</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.actatropica.2008.02.004</pub-id>, PMID: <pub-id pub-id-type="pmid">18359001</pub-id></citation></ref>
<ref id="ref62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Trocoli Torrecilhas</surname> <given-names>A. C.</given-names></name> <name><surname>Tonelli</surname> <given-names>R. R.</given-names></name> <name><surname>Pavanelli</surname> <given-names>W. R.</given-names></name> <name><surname>da Silva</surname> <given-names>J. S.</given-names></name> <name><surname>Schumacher</surname> <given-names>R. I.</given-names></name> <name><surname>de Souza</surname> <given-names>W.</given-names></name> <etal/></person-group>. (<year>2009</year>). <article-title><italic>Trypanosoma cruzi</italic>: parasite shed vesicles increase heart parasitism and generate an intense inflammatory response</article-title>. <source>Microbes Infect.</source> <volume>11</volume>, <fpage>29</fpage>&#x2013;<lpage>39</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.micinf.2008.10.003</pub-id>, PMID: <pub-id pub-id-type="pmid">19028594</pub-id></citation></ref>
<ref id="ref63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Urquiza</surname> <given-names>J. M.</given-names></name> <name><surname>Burgos</surname> <given-names>J. M.</given-names></name> <name><surname>Ojeda</surname> <given-names>D. S.</given-names></name> <name><surname>Pascuale</surname> <given-names>C. A.</given-names></name> <name><surname>Leguizamon</surname> <given-names>M. S.</given-names></name> <name><surname>Quarleri</surname> <given-names>J. F.</given-names></name></person-group> (<year>2017</year>). <article-title>Astrocyte apoptosis and HIV replication are modulated in host cells coinfected with <italic>Trypanosoma cruzi</italic></article-title>. <source>Front. Cell. Infect. Microbiol.</source> <volume>7</volume>:<fpage>345</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fcimb.2017.00345</pub-id>, PMID: <pub-id pub-id-type="pmid">28824880</pub-id></citation></ref>
<ref id="ref64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Valcour</surname> <given-names>V.</given-names></name> <name><surname>Sithinamsuwan</surname> <given-names>P.</given-names></name> <name><surname>Letendre</surname> <given-names>S.</given-names></name> <name><surname>Ances</surname> <given-names>B.</given-names></name></person-group> (<year>2011</year>). <article-title>Pathogenesis of HIV in the central nervous system</article-title>. <source>Curr. HIV/AIDS Rep.</source> <volume>8</volume>, <fpage>54</fpage>&#x2013;<lpage>61</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11904-010-0070-4</pub-id>, PMID: <pub-id pub-id-type="pmid">21191673</pub-id></citation></ref>
<ref id="ref65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vargas-Zambrano</surname> <given-names>J. C.</given-names></name> <name><surname>Lasso</surname> <given-names>P.</given-names></name> <name><surname>Cuellar</surname> <given-names>A.</given-names></name> <name><surname>Puerta</surname> <given-names>C. J.</given-names></name> <name><surname>Gonzalez</surname> <given-names>J. M.</given-names></name></person-group> (<year>2013</year>). <article-title>A human astrocytoma cell line is highly susceptible to infection with <italic>Trypanosoma cruzi</italic></article-title>. <source>Mem. Inst. Oswaldo Cruz</source> <volume>108</volume>, <fpage>212</fpage>&#x2013;<lpage>219</lpage>. doi: <pub-id pub-id-type="doi">10.1590/0074-0276108022013014</pub-id>, PMID: <pub-id pub-id-type="pmid">23579802</pub-id></citation></ref>
<ref id="ref66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname> <given-names>D. M.</given-names></name> <name><surname>Oghumu</surname> <given-names>S.</given-names></name> <name><surname>Gupta</surname> <given-names>G.</given-names></name> <name><surname>McGwire</surname> <given-names>B. S.</given-names></name> <name><surname>Drew</surname> <given-names>M. E.</given-names></name> <name><surname>Satoskar</surname> <given-names>A. R.</given-names></name></person-group> (<year>2014</year>). <article-title>Mechanisms of cellular invasion by intracellular parasites</article-title>. <source>Cell. Mol. Life Sci.</source> <volume>71</volume>, <fpage>1245</fpage>&#x2013;<lpage>1263</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00018-013-1491-1</pub-id>, PMID: <pub-id pub-id-type="pmid">24221133</pub-id></citation></ref>
<ref id="ref67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weinkauf</surname> <given-names>C.</given-names></name> <name><surname>Salvador</surname> <given-names>R.</given-names></name> <name><surname>Pereiraperrin</surname> <given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Neurotrophin receptor TrkC is an entry receptor for <italic>Trypanosoma cruzi</italic> in neural, glial, and epithelial cells</article-title>. <source>Infect. Immun.</source> <volume>79</volume>, <fpage>4081</fpage>&#x2013;<lpage>4087</lpage>. doi: <pub-id pub-id-type="doi">10.1128/IAI.05403-11</pub-id>, PMID: <pub-id pub-id-type="pmid">21788388</pub-id></citation></ref>
<ref id="ref68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname> <given-names>J. J.</given-names></name> <name><surname>Gupta</surname> <given-names>S.</given-names></name> <name><surname>Guan</surname> <given-names>Z.</given-names></name> <name><surname>Dhiman</surname> <given-names>M.</given-names></name> <name><surname>Condon</surname> <given-names>D.</given-names></name> <name><surname>Lui</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Phenyl-alpha-tert-butyl-nitrone and benzonidazole treatment controlled the mitochondrial oxidative stress and evolution of cardiomyopathy in chronic chagasic rats</article-title>. <source>J. Am. Coll. Cardiol.</source> <volume>55</volume>, <fpage>2499</fpage>&#x2013;<lpage>2508</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jacc.2010.02.030</pub-id>, PMID: <pub-id pub-id-type="pmid">20510218</pub-id></citation></ref>
<ref id="ref69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname> <given-names>J. J.</given-names></name> <name><surname>Nagajyothi</surname> <given-names>F.</given-names></name> <name><surname>Machado</surname> <given-names>F. S.</given-names></name> <name><surname>Weiss</surname> <given-names>L. M.</given-names></name> <name><surname>Scherer</surname> <given-names>P. E.</given-names></name> <name><surname>Tanowitz</surname> <given-names>H. B.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Markers of oxidative stress in adipose tissue during <italic>Trypanosoma cruzi</italic> infection</article-title>. <source>Parasitol. Res.</source> <volume>113</volume>, <fpage>3159</fpage>&#x2013;<lpage>3165</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00436-014-3977-7</pub-id>, PMID: <pub-id pub-id-type="pmid">24948102</pub-id></citation></ref>
<ref id="ref70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname> <given-names>R.</given-names></name> <name><surname>Yao</surname> <given-names>H.</given-names></name> <name><surname>Peng</surname> <given-names>F.</given-names></name> <name><surname>Yang</surname> <given-names>Y.</given-names></name> <name><surname>Bethel-Brown</surname> <given-names>C.</given-names></name> <name><surname>Buch</surname> <given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>Cooperative induction of CXCL10 involves NADPH oxidase: implications for HIV dementia</article-title>. <source>Glia</source> <volume>58</volume>, <fpage>611</fpage>&#x2013;<lpage>621</lpage>. doi: <pub-id pub-id-type="doi">10.1002/glia.20949</pub-id>, PMID: <pub-id pub-id-type="pmid">19941336</pub-id></citation></ref>
</ref-list>
<fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This work was supported by the Agencia Nacional de Promoci&#x00F3;n Cient&#x00ED;fica y Tecnol&#x00F3;gica of Argentina (grant numbers No. PICT-2015-1921 to JQ and No. PICT-2015-0316 to MD).</p></fn></fn-group>
</back>
</article>